WO2006127542A2 - System and method for grading microemboli monitored by a multi-gate doppler ultrasound system - Google Patents
System and method for grading microemboli monitored by a multi-gate doppler ultrasound system Download PDFInfo
- Publication number
- WO2006127542A2 WO2006127542A2 PCT/US2006/019637 US2006019637W WO2006127542A2 WO 2006127542 A2 WO2006127542 A2 WO 2006127542A2 US 2006019637 W US2006019637 W US 2006019637W WO 2006127542 A2 WO2006127542 A2 WO 2006127542A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- microemboli
- blood flow
- signals
- period
- value
- Prior art date
Links
- 238000002604 ultrasonography Methods 0.000 title claims abstract description 79
- 238000000034 method Methods 0.000 title claims abstract description 45
- 230000017531 blood circulation Effects 0.000 claims abstract description 63
- 238000012544 monitoring process Methods 0.000 claims abstract description 48
- 230000004044 response Effects 0.000 claims abstract description 18
- 239000000523 sample Substances 0.000 claims description 52
- 238000012545 processing Methods 0.000 claims description 44
- 230000008569 process Effects 0.000 claims description 13
- 230000002146 bilateral effect Effects 0.000 claims description 8
- 230000003727 cerebral blood flow Effects 0.000 claims description 6
- 208000008883 Patent Foramen Ovale Diseases 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 2
- 235000019800 disodium phosphate Nutrition 0.000 description 30
- 239000011159 matrix material Substances 0.000 description 27
- 238000010586 diagram Methods 0.000 description 14
- 230000003073 embolic effect Effects 0.000 description 13
- 239000013598 vector Substances 0.000 description 12
- 208000005189 Embolism Diseases 0.000 description 10
- 208000006011 Stroke Diseases 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 9
- 238000003745 diagnosis Methods 0.000 description 9
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 238000013175 transesophageal echocardiography Methods 0.000 description 7
- 208000032382 Ischaemic stroke Diseases 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 210000001367 artery Anatomy 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 208000035478 Interatrial communication Diseases 0.000 description 4
- 206010003664 atrial septal defect Diseases 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 238000001356 surgical procedure Methods 0.000 description 4
- 238000012549 training Methods 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- 208000019695 Migraine disease Diseases 0.000 description 3
- 208000002121 Paradoxical Embolism Diseases 0.000 description 3
- 208000036758 Postinfectious cerebellitis Diseases 0.000 description 3
- 206010041235 Snoring Diseases 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 238000007726 management method Methods 0.000 description 3
- 206010027599 migraine Diseases 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 208000035126 Facies Diseases 0.000 description 2
- 206010073734 Microembolism Diseases 0.000 description 2
- 208000032109 Transient ischaemic attack Diseases 0.000 description 2
- 206010047249 Venous thrombosis Diseases 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 238000013500 data storage Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 239000002961 echo contrast media Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 210000005246 left atrium Anatomy 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000003582 temporal bone Anatomy 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 201000010875 transient cerebral ischemia Diseases 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- KRQUFUKTQHISJB-YYADALCUSA-N 2-[(E)-N-[2-(4-chlorophenoxy)propoxy]-C-propylcarbonimidoyl]-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one Chemical compound CCC\C(=N/OCC(C)OC1=CC=C(Cl)C=C1)C1=C(O)CC(CC1=O)C1CCCSC1 KRQUFUKTQHISJB-YYADALCUSA-N 0.000 description 1
- 206010003658 Atrial Fibrillation Diseases 0.000 description 1
- 206010003791 Aura Diseases 0.000 description 1
- 206010051055 Deep vein thrombosis Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 208000010378 Pulmonary Embolism Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 210000002551 anterior cerebral artery Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000001746 atrial effect Effects 0.000 description 1
- 208000013914 atrial heart septal defect Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002592 echocardiography Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 210000004704 glottis Anatomy 0.000 description 1
- 210000002837 heart atrium Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 210000004971 interatrial septum Anatomy 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000003447 ipsilateral effect Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000015654 memory Effects 0.000 description 1
- 210000003657 middle cerebral artery Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 238000002610 neuroimaging Methods 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 210000005245 right atrium Anatomy 0.000 description 1
- 210000005241 right ventricle Anatomy 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 238000012956 testing procedure Methods 0.000 description 1
- 210000005243 upper chamber Anatomy 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/06—Measuring blood flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/08—Clinical applications
- A61B8/0808—Clinical applications for diagnosis of the brain
Definitions
- the invention relates generally to Doppler ultrasound systems, and more particularly, a system and method for grading microemboli, such as ultrasonic contrast agents that move in blood flow, using a multi-gate Doppler ultrasound system.
- Cryptogenic strokes and transient ischemic attacks are those in which no obvious cause is found by patient history, carotid Doppler studies, or cardiac conditions such as atrial fibrillation, myocardial infarction, or valve diseases.
- Patent foramen ovale which is a small flap-valve hole in the heart, has been associated with cryptogenic stroke allowing paradoxical embolism from the veins to the brain through a right-to-left shunt (“RLS").
- RLS right-to-left shunt
- the venous blood which may contain clots, may instead travel through the hole (i.e., the PFO) between the upper chambers of the heart and into the arterial blood, bypassing the lungs where the clots would normally be filtered out.
- the PFO the hole between the upper chambers of the heart and into the arterial blood, bypassing the lungs where the clots would normally be filtered out.
- a clot may cause a stroke or stroke- like symptoms.
- the underlying cause is difficult to determine and the stroke is called "cryptogenic".
- Evidence now suggests that when a person has a stroke, and its cause is undetermined, the person is about twice as likely as the normal population to have PFO.
- PFO is found in all ages; 34% of adults in the first three decades of life declining to 20% in the 9th and 10th decades and ranging from 1 to 19mm in diameter.
- Cryptogenic stroke patients assessed with traditional single gate transcranial Doppler ("sgTCD"), have 12 to 1 odds of having a large PFO compared to a non-stroke group.
- migraine patients with aura have a 3 to 1 odds of having a PFO compared to a non- migraine group.
- Conditions for venous thrombosis and pulmonary embolism also exist widely and deep vein thrombosis is a common finding in the vascular laboratory. Therefore, the conditions for paradoxical embolism are widely prevalent at all ages.
- Atrial septal defect is a permanent opening through the interatrial septum that often persists into adulthood. Blood flows back and forth through the defect depending on the back and forth pressure gradient between the atria. This defect usually places a load on the right ventricle that, however, may be tolerated for many years. If the mean right atrial pressure is chronically elevated these patients have a significant desaturation of the arterial blood.
- TCD over invasive transesophageal echocardiography has enhanced the search for PFO and ASD.
- sgTCD has demonstrated high accuracy in ruling in, and ruling out, PFO when compared to TEE. .
- sgTCD is able to detect large shunts, which are more clinically relevant.
- agitated saline which provide an ultrasonic contrast agent of bubbles, the suspended bubbles pass through the PFO from the right to the left atrium and are easily detected by TCD as audible chirps and microembolic spectra in the cerebral arteries.
- Agitated saline contrast agent has been used safely for many years in echocardiography and TCD.
- bubbles in agitated saline do not pass the lungs, and therefore a shunt from the venous system to the arterial system which bypasses the lungs is the only way for bubbles to be seen on the arterial side.
- a Valsalva strain forced expiratory effort against a closed glottis
- TEE is currently considered the "gold standard" for PFO diagnosis. However, it is poorly tolerated by patients and requires deep sedation, which limits the patient's ability to . perform a Valsalva maneuver. sgTCD has proven to be a reliable technique for diagnosing PFO. While PFO diagnosis and treatment are facilitated by TCD's less invasive technology, sgTCD and TEE are limited by a grading system that uses 3 categories to rate the degree of RLS. Ih patients with ischemic or cryptogenic stroke, the need exists to further quantify RLS.
- An improvement over the use of TEE and sgTCD for evaluating PFO is provided by recently developed multi-gate power m-mode TCD (pmTCD) ultrasound devices.
- PMD multi-gate power m-mode TCD
- An example of such an ultrasound system is the digital Doppler platform developed by Spencer Technologies in Seattle, Washington in which up to 33 sample gates placed at 2 mm intervals can be simultaneously processed into a "color" power m- mode image.
- the color in the m-mode image is a function of Doppler signature power and detected velocity, in that increases in backscattered power cause the colors, red or blue, to become more intense. Additionally, a spectrogram for a selected depth in the depth range can be displayed.
- the digital Doppler platform is referred to as Spencer Technologies' Power M-mode Doppler ("PMD").
- pmTCD detects 66% more bubble microemboli than traditional sgTCD.
- the increased detectability allows for use of an expanded six-level grading scale to rate the degree of RLS, in contrast to the three-level grading system provided by TEE and sgTCD.
- bilateral monitoring is performed with the beam including the ipsilateral middle cerebral and anterior cerebral arteries ("MCAs") and ("ACAs").
- MCAs middle cerebral and anterior cerebral arteries
- ACAs ACAs
- the two probes are positioned bilaterally and stabilized using a head-frame " worn by the patient.
- the spectrogram sample volumes of the PMD are set near the origin of each respective MCA at a depth of 50 mm to 60 mm.
- the PMD is observed for embolic tracks ("ETs") while listening to the MCA spectral signal.
- pmTCD produces unique signatures of emboli, appearing as brightly colored ETs as they pass through the insonated arteries.
- a bright red upward-sloping ET is produced.
- a bright blue downward- sloping ET is produced.
- the sloping feature of the ET is prima facie evidence of an embolus (i.e., a bubble or particle) carried by the blood through a vessel within the ultrasound beam. The slope shows the embolus velocity as a change in depth over time. If the single gate is placed in any of the colored bands, ETs also appear on the spectrogram as high intensity microembolic signals ("MESs").
- MESs high intensity microembolic signals
- the expanded six-level grading scale does not predict the size of the opening, but does provide a measure of the conductance or ability of the opening to transmit material from the venous circulation to the brain. That is, the numbers of ETs represent tracers of the conductance of RLS flow to the anterior circulation of the brain. The conductance takes into account many factors including the RLS flow distribution to the anterior circulation of the brain, the size of the foramen while open, and the right-to- left pressure gradient when the foramen is open. For unilateral pmTCD monitoring, the number of ETs counted are doubled and the resulting number applied to the six-level grading scale accordingly.
- aspects of the invention include systems and methods for grading signals from microemboli in blood flow that is monitored using a Doppler ultrasound system.
- the signals from microemboli in blood flow are graded by calculating a value related to a power for the signals from microemboli in blood flow and categorizing the signals from microemboli in blood flow into one of at least two grades based on the calculated value.
- categorizing microemboli in blood flow monitored using a Doppler ultrasound system includes assessing a power value for the microemboli in the blood flow during a period of monitoring.
- Figure 1 is a functional block diagram of a Doppler ultrasound system in which embodiments of the present invention can be implemented.
- Figure 2 is a functional block diagram of a portion of a Doppler digital signal processor ("DSP") platform of the Doppler ultrasound system of Figure 1.
- DSP Doppler digital signal processor
- Figure 3A is a functional block diagram of a transmit circuit of the DSP platform of Figure 2.
- Figure 3B is a functional block diagram of a receive circuit of the
- FIG. 4 is a flow diagram for Doppler shift signal processing performed by the
- Figure 5 is a flow diagram for a grading algorithm according to an embodiment of the present invention using Doppler shift data from the DSP platform of Figure 2.
- Figure 6 is a flow diagram for Doppler shift data processing of Figure 5 according to an embodiment of the present invention.
- Figures 7A-7F are PMD/spectrogram images for various grades of functional conductance of PFO.
- Figure 8 is a flow diagram for a grading algorithm according to another embodiment of the present invention.
- Figure 9 is a flow diagram for a grading algorithm according to another embodiment of the present invention.
- Figure 10 is a flow diagram for a grading algorithm according to another embodiment of the present invention.
- Figure 11 is a flow diagram for Doppler shift data processing of Figure 10 according to an embodiment of the present invention.
- Figure 12 is a flow diagram for processing data in Figure 10 according to an alternative embodiment of the present invention.
- the present invention includes embodiments directed to automatically grading and/or counting embolic signatures detected using a multi-gate Doppler ultrasound system.
- One embodiment of the present invention which will be described in more detail below, can be used with a multi-gate pmTCD ultrasound device for grading the functional conductance of PFO.
- Alternative embodiments of the present invention can also be used in other applications where grading and/or counting ETs during monitoring cerebral blood flow using pmTCD is desirable, including, monitoring the brain during heart surgery, carotid surgery, orthopedic surgery, or other procedure where significant invasive activity may potentially release emboli returning to the heart in the venous system. Certain details are set forth below to provide a sufficient understanding of the invention.
- FIG. 1 is a functional block diagram of a multi-gate Doppler ultrasound system 100 in which an embodiment of the present invention can be implemented.
- the ultrasound system 100 includes a Doppler DSP platform 200 coupled to a probe 112 having an ultrasound transducer 113.
- the Doppler DSP platform 200 provides for generating transmit waveforms to drive the transducer of the probe 112, digitizing echo signals detected by the transducer 113 of the probe 112, and signal processing to generate Doppler shift data representative of Doppler shift signals extracted from the echo signals.
- a second probe 114 having an ultrasound transducer 115 can also be coupled to the DSP 200 where bilateral monitoring of cerebral blood flow is desirable.
- the probe 114 can be the same in structure and functionality as the probe 112 previously described. Consequently, a more detailed description of the probe 114 has not been provided herein.
- the Doppler DSP platform 200 is further capable of controlling the transmit function of both the probes, as well as process the echo signals detected by the probes 112, 114 in order to generate Doppler shift data representing Doppler shift signals extracted from the echo signals.
- a separate channel is provided for each probe 112, 114.
- various circuits are shared between the two channels while other circuits are kept separate. It will be appreciated by those ordinarily skilled in the art that the particular arrangement of the circuits described herein are not intended to limit the scope of the present invention.
- the DSP platform 200 is coupled to a processing system 120 through a bus 122.
- the bus 122 can be implemented using conventional computer busses and protocols, for example, the bus 122 can be a universal serial bus ("USB").
- the processing system 120 is configured for additional processing of Doppler shift data provided by the DSP platform 200.
- the processing system 120 also provides the DSP platform 200 with, among other things, commands and data for controlling the functions of the DSP platform 200. Additionally, the processing system 120 executes a grading algorithm for grading and/or counting ETs detected by the ultrasound system 100, as described in more detail below.
- the processing system 120 can be a host computer system to which the DSP platform 200 is coupled, or alternatively, can represent processing systems included with the DSP platform 200, or in an ultrasound system in which the DSP platform 200 is included for standalone Doppler processing.
- the processing system 120 is coupled to a display device 126 for providing visual information and feedback to an operator.
- the information can be displayed in different formats on the display device 126.
- blood flow information can be displayed in a PMD format, as described in U.S. Patent No. 6,196,972 to Moehring, which is incorporated herein by reference.
- the display device 126 can be a conventional display device now known or later developed, including a flat panel display or cathode ray tube (“CRT”) display, which can be integrated with the ultrasound system 100, or is a standalone display device connected to the processing system 120.
- CTR cathode ray tube
- the processing system 120 is further coupled to a data storage device 130 to store data or retrieve data from external storage media.
- Examples of typical data storage devices 130 include hard and floppy disks, tape cassettes, compact disk read- only ("CD-ROMs”) and compact disk read-write (“CD-RW”) memories, and digital video disks ("DVDs").
- the ultrasound system 100 is also coupled to audio speakers 132 for providing audio information, and is further coupled to a microphone 134 for receipt of audible information input by an operator.
- One or more input devices 136 such as a keyboard or a mouse, are included in the ultrasound system 100 to allow the operator to interface with the ultrasound system 100.
- the processing system 120 can further include conventional circuits and software for storing the audio and visual information for later playback and viewing.
- Figure 2 illustrates a portion of the circuits included in the DSP platform 200.
- the DSP platform 200 includes a TX/RX/DSP-chamel 201 coupled to the transducer
- the TX/RX/DSP-channel 201 includes transmit and receive circuits 210 and 212, respectively, coupled to a DSP 218 through a logic circuit 216.
- the logic circuit 216 represents a front end processor that is used for performing repetitive tasks in the processing chain and provides a link between the analog front end of the TX/RX/DSP-channel 201 represented by the transmit and receive circuits 210 and 212, and the digital environment of the DSP 218.
- the TX/RX/DSP-channel 201 is coupled through the data bus 122 to the processing system 120.
- the processing system 120 can represent a host computer system, processing systems included with the DSP platform 200, processing systems included in the ultrasound system 100, or some other alternative processing system.
- a second TX/RX/DSP-channel (not shown, the same as the TX/RX/DSP- channel 201) can be included in the DSP platform 200.
- FIGs 3 A and 3B illustrate the transmit circuit 210 and the receive circuit 212, respectively, that are included in the TX/RX/DSP-channel 201 ( Figure 2).
- the transmit and receive circuits 210, 212 are coupled to the ultrasound transducer 113 of the probe 112 to provide transmit and receive functionality, respectively, to the probe 112.
- the transmit circuit 210 receives control signals from the processing system 120 to control the ultrasound beam delivered by the prove 112.
- the control signals provided to the transmit circuit 210 can be used to set gain, carrier frequency, length of the transmit burst and pulse repetition frequency ("PRF").
- PRF pulse repetition frequency
- the transducer 113 is driven to deliver pulsed ultrasound having a carrier frequency of 2 MHz and a PRF of 8 kHz.
- the DSP 218 provides the appropriate digital commands to the logic circuit 216 to activate a particular mode (i.e., transmit or receive) of operation.
- the logic circuit 216 generates two digital logic pulse trains Vl and V2 with the specified carrier frequency (divider applied to external clock), PRF, and pulse length.
- the two pulse trains Vl and V2 signals are provided to an operational amplifier 220 included in the transmit circuit 210, are added 180 degrees out of phase, and amplified by the operational amplifier 220 according to the gain specified by the control signals from the processing system 120.
- the operational amplifier 220 is preferred to provide approximately 40 dB of programmable transmit gain. However, amplifiers having other gain characteristics can be used as well.
- the specified gain is provided to the logic circuit 216 as digital data, which is converted by a digital-to-analog converter ("DAC") 222 into an analog gain signal applied to the operational amplifier 220.
- DAC digital-to-analog converter
- the resulting output signal from the operational amplifier 220 is a square "sinusoid" with center voltage of zero volts.
- the amplified signal is then applied to the transducer 113 through a tuning circuit (not shown in Figure 3) to drive the transducer 113 to deliver pulsed ultrasound having a pulse period corresponding to the PRF.
- the receive circuit 212 receives echo signals detected by the transducer 113.
- the echo signals are provided to a receive amplifier 224.
- the amplifier 224 provides a fixed gain of approximately 40 dB and bandpass filtering with a center frequency of 2 MHz and a bandwidth of approximately 300 kHz. Other carrier frequencies and corresponding center frequencies can be used as well.
- the amplified and bandpass-filtered echo signals are sampled at four times the carrier frequency by an analog-to-digital converter ("ADC") 226 to provide digital echo data representative of the amplified and bandpass-filtered echo signals.
- ADC analog-to-digital converter
- the sampling frequency 8 MHz based on a carrier frequency of 2 MHz.
- the echo data are processed by the logic circuit 216 to demodulate the echo signals for a pulse period of ultrasound into Doppler (I, Q) shift samples that stratify the depth range of interest along the ultrasound beam.
- I represents a measure of a Doppler shift sample along an "in-phase” or “real” axis of the complex plane
- Q represents a measure of the Doppler shift sample at essentially the same time and position, but on a "quadrature” or “imaginary” axis of the complex plane.
- the echo data generated by the ADC 226 are also output by the logic circuit 216.
- the Doppler (I, Q) shift samples and the echo data generated by the logic circuit 216 are provided to respective DSPs 218 ( Figure 2) to construct Doppler shift signals from multiple Doppler shift samples.
- Each Doppler shift signal is constructed from Doppler shift samples from the same echo depth and across multiple pulse periods.
- the Doppler shift signals are represented by Doppler shift data that are output by the respective DSPs 218.
- Figure 9 is a flow diagram illustrating the signal and data processing performed by the DSP platform 200 for echo signals detected by the transducer 113 ( Figure 1).
- the echo signals are amplified and band-pass filtered at the carrier frequency at step 402.
- the amplified and band-pass filtered echo signals are then digitized to provide digital echo data representing the amplified and band-pass filtered echo signal at step 404.
- the echo data is demodulated at step 406 to generate Doppler (I 5 Q) shift samples for the depth range.
- the Doppler (I 5 Q) shift signals are low-pass filtered at step 408 to remove noise outside the bandwidth of the transmit signal. Demodulation and low-pass filtering are performed within each pulse period.
- the low-pass filtered Doppler (I 5 Q) shift samples are decimated to carry forward only candidate signals from the depth or depth range of interest.
- Doppler shift signals represented by Doppler shift data are constructed at step 410 from the Doppler (I 5 Q) shift samples from multiple pulse periods.
- the Doppler shift signals are clutter filtered at step 412 to suppress "clutter" from each Doppler shift signal.
- steps 402-412 are generally performed by the DSP platform 200.
- Suitable methods for demodulating, low-pass filtering and decimating are described in greater detail in the aforementioned U.S. Patent No. 6,196,972 to Moehring. However, it will be appreciated that other methods can be used as well.
- the aforementioned patent describes a demodulation process for generating Doppler (I 3 Q) shift samples that can be performed through simple subtraction operations operating on each successive quartet of samples of echo data for a pulse period.
- Each sample corresponds to digital echo data resulting from sampling the signal output by the receive amplifier 224 at four-times the carrier frequency.
- the third value is subtracted from the first value to produce the real part "I” and the second value is subtracted from the fourth value to produce the imaginary part "Q" of a complex Doppler (I,Q) shift sample for an associated depth.
- the same operation is performed on all quartets of samples of echo data for a pulse period, with each succeeding quartet of points associated with a location of greater depth.
- the particular demodulation method blurs the axial resolution by approximately one wavelength of the carrier, but is acceptable in typical applications since one wavelength of the carrier is inconsequential relative to the typical sample volume size associated with medical pulse Doppler ultrasound.
- Clutter cancellation can be accomplished with infinite impulse response ("HR") filters, as described in detailed in the aforementioned U.S. Patent No. 6,196,972 to Moehring. However, other clutter cancellation filters can be used as well.
- the clutter filtered Doppler shift data is then provided to the processing system 120 from the DSP platform 200 where it further processed. For example, the data can be processed by the processing system 120 to construct a PMD image for display on the display 126 ( Figure 1) to provide visual feedback to an operator regarding blood flow in a region interrogated by ultrasound.
- construction of an image from the Doppler shift data can be accomplished using conventional techniques now known by those ordinarily skilled in the art, for example, as described in the aforementioned U.S. Patent No. 6,196,972 to Moehring, or later developed. Consequently, in the interest of brevity, a detailed discussion of constructing such an image is omitted from herein.
- Doppler shift data provided by the DSP platform 200 can be further processed in order to grade and/or count MESs detected using the ultrasound system 100.
- the particular embodiment described below is directed to grading functional conductance of PFO according to various grading scales.
- alternative embodiments of the present invention can be utilized in other applications as well. From the description provided herein, those ordinarily skilled in the art will obtain sufficient understanding to practice the invention in various applications, and consequently, the scope of the invention should not be limited to the particular embodiments described herein.
- FIG. 5 is a flowchart for an algorithm that performs automatic grading of the functional conductance of a PFO.
- the embolic signatures evaluated by the algorithm are bubbles injected into a patient in accordance with a conventional protocol for evaluating PFO in the patient.
- the contrast bubble ETs are . monitored following the release of the Valsalva maneuver and continues for a time period thereafter.
- the Doppler shift data provided by the DSP platform 200 ( Figure 1) is processed to calculate a value related to the energy of bubble ETs detected following the release of the Valsalva maneuver and during the subsequent monitoring period.
- the functional conductance of the PFO is graded according to a grading scale that generally corresponds to a conventional six-level logarithmic scale that is typically used for PFO evaluation based on visually counting bubble ETs detected by a multi-gate pmTCD ultrasound device.
- the conventional six- level logarithmic grading scale is as follows:
- the grading scale used in the present embodiment of the invention has seven grades that generally correspond to the conventional grading scale. More specifically, the seven grades are: Grade 0, Grade 1, Grade 2, Grade 3, Grade 4, Grade 5, and Grade 5+ (5+ is distinguished from 5 in that it has at least a two heart cycle period during which there is a homogenous white-out of the spectrum and the m-mode display.
- the algorithm performs grading at steps 504-516 by comparing the value calculated at step 502 to respective threshold values defining the different grades. The values used for the thresholds will be discussed in more detail below.
- Doppler shift data of step 502 ( Figure 5).
- Matrices will be identified herein by a variable, and entries in a matrix are identified by indices j and k , where j represents a row index and k represents a column index, as known.
- a matrix Q has a dimension of M rows and N columns.
- the respective matrix is identified by "R" for the right channel and "L" for the left channel.
- the matrix Q for the right channel is identified as Q R and the matrix Q for the right channel is identified as Q L .
- matrices B R and B L of background Doppler signal power data are constructed from Doppler shift data acquired from the left and right channels.
- the Doppler signal power is calculated for a period of 10 seconds during normal respiration by the patient, however, time periods other than 10 seconds can be used as well. Assuming that the ultrasound delivered to the patient has a PRF of 8 kHz, and the Doppler shift signal power is calculated using 64 pulse periods (i.e., a Doppler shift signal power value is calculated every 8 ms), 1,250 Doppler shift signal power values are calculated over the 10 seconds of monitoring.
- Doppler shift data acquired from the left and right channels shortly after the release of the Valsalva maneuver is calculated for a period of 60 seconds, although in other embodiments different time periods can be used.
- a matrix of 17 rows by 7,500 columns of Doppler shift signal power is constructed for each channel.
- the 17 rows represent 17 different depths over the depth range of 44-76 mm in 2 mm gate intervals
- the 7,500 columns represent the number of Doppler shift signal power values calculated over the 60 seconds, each value calculated from 64 pulse periods of ultrasound having a PRF of 8 kHz.
- each of the matrices is constructed by dividing all Doppler shift signal power values S R tk , S j>k in a row of the signal matrix S R , S L by a mean Doppler Shift signal power ("mean background power vector," Z. ) calculated from the Doppler shift signal power values Bj k , Bj k in the corresponding row of the corresponding (i.e., left or right channel) background matrix B R , B L .
- the resulting mean background power vectors Z 3 define a mean background power matrix for each channel, Z R and Z L .
- Each matrix Z R , Z L has dimensions of 17 rows and 1 column. The 17 rows correspond to the 17 different depths and the 1 column corresponds to a respective mean background power vector at each of the 17 depths.
- the two resulting matrices (i.e., left and right channels) of signal-to-background ratios T R , T L have dimensions of 17 rows by 7,500 columns.
- a mean background power value is calculated, a median power value can be alternatively used in calculating the values T R k , ⁇ £ k for the matrices of signal-to- background ratios T R , T L .
- a beam power analysis is performed for each channel.
- the vectors are summed from each channel to provide to values P R and P L corresponding to the beam power for each of the channels.
- the values P R and P L are expressed in terms of decibels.
- the signal-to-background ratios Tf k , Tf k of the matrices T R , T L are converted into decibels, and result in two matrices V R and V L .
- the matrices V R and V L are analyzed to determine which of the signal-to-background ratios (in dB) likely correspond to a bubble embolic signature.
- every signal-to-background ratio Vf k , Vf k of the matrices V R and V L exceeding a factor of 10 is considered to be a likely candidate corresponding to a. bubble signal.
- the results of the determination are used to construct two binary bubble signal matrices ⁇ R and ⁇ L (i.e., one for the right channel and one for the left channel).
- Each binary matrix ⁇ R , ⁇ ⁇ includes binary values ⁇ R k , ⁇ ) k ("1" or "0") arranged in 17 rows and 7,500 columns.
- Each "1” indicates that the signal-to- background ratio Vf k , Vf k for the corresponding location in the matrix of signal-to- background ratios V R , V L exceeded a factor of 10 and each "0" indicates that the signal-to-background ratio Vf k , Vf k for the corresponding location in the matrix of signal-to-background ratios V R , V L did not exceed a factor of 10.
- filtered bubble signal matrices F R and F 1 are constructed for each channel by multiplying the signal matrices V R and V L (in dB) with the binary matrices ⁇ R , ⁇ L . [060] where (0.4)
- Each, of the matrices F R and F L have dimensions of 17 rows by 7,500 columns.
- linear domain bubble matrices D R and D L are constructed for each channel by converting the values F R k , Ff ⁇ of the filtered bubble signal matrices F R and F L into the linear domain from the decibel domain.
- step 618 cross correlation of each one-half second interval with the following one-half second interval is performed.
- Each of the matrices D R and D L are divided into sets of overlapping sub- matrices having dimensions of 17 rows and 128 columns. Each of the sub-matrices roughly represents data for 17 different depths over approximately a one second period, hi the present embodiment, the overlap between adjacent sub-matrices is 50%.
- Ho IrTt(N 5 ZAfJ -I sub-matrices in 60 seconds of data.
- matrix B(i) is defined having the last 64 columns of the same sub-matrix, where i denotes the particular sub-matrix.
- the algorithm calculates and integrates a correlative vector, R. , for each of the sub-matrices, and thereby formulate a vector C R , C L for each channel as follows ( C has dimensions 1 x 116):
- C R , C L axe referred to as "bubble vectors" because they are primary indicators of when bubble shower activity is occurring across the 60 seconds following bubble injection for PFO detection.
- the amplitude of the individual bubbles towards the magnitude of C R , C L is somewhat softened compared to the amplitude contributions towards directly summing the signals in matrices D R , D L . Bubbles that do not have neighboring bubbles do not make as strong a contribution as bubbles with nearby neighbors.
- a shower index is calculated.
- the C R , C L vectors are summed and converted to decibels to give two floating point values Z R and Z L corresponding to the bubble values in the two channels.
- the particular autocorrelation measure increases with the intensity of bubble showers and with duration of bubble showers.
- the operation results in a parameter for sorting high grade showers from low grade showers.
- the shower indices Z R and Z L are weighted according to their beam values to produce a weighted shower index H.
- the weighted shower index H is the value that is used for grading the functional conductance of Hie PFO. In one embodiment, a seven-level grading scale is used for the functional conductance of the PFO.
- the first threshold from step 504 is 125 dB
- the second threshold from step 506 is 110 dB
- the third threshold from step 508 is 100 dB
- the fourth threshold from step 510 is 80 dB
- the fifth threshold from step 512 is 60 dB
- the sixth threshold from step 514 is 40 dB.
- Other embodiments of the invention can use different threshold values.
- the threshold values have been provided herein by way of example.
- Alternative embodiments of the present invention can use different threshold values, and additionally, other alternative embodiments can use greater or fewer grade levels than that previously described.
- Figures 7A-7F are a series of PMD/spectrogram images for different patients of a study that included 200 patients for which data was gathered. There was some overlap with the patient population noted in Spencer et al., Power M-Mode Transcranial Doppler for Diagnosis of Patent Foramen Ovale and Assessing Transcatheter Closure, J Neuroimaging 2004; 14:342-349.
- the PMD/spectrogram images of Figures 7A-7F are taken over a four second period following the release of the Valsalva maneuver.
- Figures 7A-7F illustrate four second periods, the grading, as previously discussed, is based on the number of embolus visually counted over a 60 second period of monitoring.
- the TCD IOOM platform has 33 gates placed at 2 mm intervals along the ultrasound beam.
- the M-mode display covers a depth range of 25-85 mm and there is an accompanying spectrogram which presents spectral analysis of a user-selected depth in the M-mode display.
- the insonation method for this equipment has been described in Moehring et al., Power M-Mode Doppler (PMD) For Observing Cerebral Blood Flow and Tracking Emboli, Ultrasound in Med. & Biol, Vol. 28, No. 1, pp. 49-57, 2002.
- the ultrasound beam can observe the proximal MCA and the proximal ACA concurrently in most patients.
- Bilateral monitoring was performed with each probe held in place over a temporal bone by a Marc 600 head frame (Spencer Technologies, Seattle, WA). An MCA gate was selected for each spectrogram. A computer hard disk provided continuous recording that was replayed for manual counting bubble embolic signals, and then used in training the automatic grading algorithm.
- Ih contrast when an embolus moves away from the transducer, a bright blue downward-sloping ET is produced.
- the sloping feature of the ET is prima facie evidence of an embolus (i.e. a bubble or particle) carried by the blood through a vessel within the ultrasound beam.
- the slope shows the embolus velocity as a change in depth over time. If the single gate is placed in any of the colored bands, ETs also appear on the spectrogram as spectral MESs.
- the ETs in the bilaterally insonated arteries from a depth of 46 mm to 76 mm were used for grading — both automatic and manual — since there is a beam overlap with the beam from the opposite side of the head at the midline (i.e., a depth of 75 mm).
- the Spencer PFO protocol was followed for all the patients in the study, which is a superset of the patients studied in the Spencer et al. article.
- a minimum of 2 contrast bolus injections were agitated and administered antecubitally (arm vein) while the patient was in recumbent position. The first injection was performed during normal respiration and the second performed immediately prior to a calibrated Valsalva. As suggested in Spencer et al. article, the best results are obtained when a Valsalva is performed during bubble injection. Only the data associated with Valsalva was used in developing the automatic grading algorithm according to the previously described embodiment.
- the algorithm for automatic grading of the functional conductance of a PFO is modified from the seven-level grading scale to a simplified three-level grading scale, as shown in Figure 8.
- the grading algorithm of Figure 8 uses the value calculated from the Doppler shift data processing of Figure 6 to determine whether there is a null result (steps 804 and 805), a grade lower than grade 4 (steps 806 and 807), or a grade of grade 4 or higher (steps 806 and 808).
- the information provided by the automatic grading algorithm of Figure 8 constitutes a finding which informs a physician who will interpret the finding, come to a diagnosis, and determine appropriate clinical management based on the diagnosis.
- Figure 9 illustrates a grading algorithm according to another embodiment of the present invention.
- the algorithm of Figure 9 uses a simplified three-level grading scale.
- the grading algorithm of Figure 9 uses the value calculated from the Doppler shift data processing of Figure 6 to determine whether there is a null result (steps 904 and 905), a grade lower than grade 3 (steps 906 and 907), or a grade of grade 3 or higher (steps 906 and 908).
- the value calculated by the Doppler shift data processing can be used in grading scales having different grade levels.
- Figure 10 is a flow chart of a grading/counting algorithm according to an embodiment of the invention for MESs that are monitored using a multi-gate Doppler ultrasound system.
- the algorithm shown in Figure 10 uses a six-level grading scale, with grades 0-5. As will be described in more detail below, the algorithm combines quantification of the energy associated with the bubble emboli and automatic identification and counting of ETs.
- the Doppler shift data is processed to calculate a first value related to the bubble ETs that are detected following the release of the Valsalva maneuver and during the subsequent time period of monitoring.
- the first value represents the energy associated with the bubble emboli.
- the process described with reference to Figure 6 can be used to calculate the first value.
- the first value is compared to a first threshold value. Ih the present embodiment, the first threshold value corresponds to the energy threshold for a grade 4 according to the modified seven-level grading scale previously discussed, that is, 100 dB. If the first value is greater than 100 dB, another comparison is made at step 1006 to the energy threshold for grade 5, which has been previously described as being 110 dB. A grade 5 is reported at step 1008 in the event the first value from step 1002 is greater than 110 dB, and a grade 4 is reported at step 1010 otherwise.
- step 1004 if the first value calculated at step 1002 is less than 100 dB, the
- Doppler shift data collected from monitoring the bubble emboli following the release of the Valsalva maneuver is further processed at step 1012 to provide a second value.
- the second value generally corresponds to the number of ETs that are identified as bubbles over a time period of analysis.
- the second value is compared at ' step 1014 to a threshold value that corresponds to the grade 3 threshold of the conventional six-level Spencer RLS conductance grading scale, in particular, 31 ETs.
- a grade 3 is reported at step 1014 if the second value is greater than 31.
- the second value is compared to a threshold value corresponding to the grade 2 threshold at step 1018, that is, 11 ETs, and is reported as a grade 2 at step 1020 if the number of bubble ETs detected is greater than 11.
- a grade of 1 or a null result is reported at steps 1024 and 1026, respectively, depending on the comparison of the second value at step 1022 to a threshold value that corresponds to a grade 1 threshold, namely, 1 ET.
- the grade provided by the automatic . grading/counting algorithm of Figure 10 constitutes a finding which informs a physician who will interpret the finding, come to a diagnosis, and determine appropriate clinical management based on the diagnosis.
- the particular embodiment of the automatic grading/counting algorithm illustrated in Figure 10 uses an energy value for the bubble ETs in making a determination between reporting a grade 5 or grade 4. For grades less than grade 4, however, the number of bubble ETs detected over the period of evaluation is used to make the grade.
- the particular details of the automatic grading/counting algorithm of Figure 10 can be modified to provide alternative embodiments.
- the energy value provided by step 1002 can be used to make a determination between grades higher than a grade 3
- the count value provided by the processing of step 1012 can be used to make a determination for grades lower than grade 3.
- not all of the grades between 0 and 5, or 5+, need to be represented.
- the energy value can be used to determine only if the grade is higher than a grade 4, and if not, identification of a specific grade of 3 or lower can be made using the count value from step 1012.
- FIG. 11 is a flowchart for Doppler shift data processing at step 1012
- the Doppler shift data is further processed to take advantage of the fact that the bubble embolic showers have "countable" ETs, and can be used to produce a count from which the PFO grade for a grade lower than grade 4 can be directly determined.
- the T R and T L matrices of signal-to-background ratios T R k , Tf k constructed at step 1002 are processed to construct median power matrices M R , M L .
- a median power value is calculated and represents an entry Mf , Mf in the median power matrices M R , M 1 .
- Each of the M R , M L matrices have a dimension of 17 rows and 1 column.
- M j median(T J ⁇ ) . . (0.10)
- the Doppler shift data is processed to construct phase matrices ⁇ R , ⁇ L having phase entries ⁇ f k , ⁇ f k .
- the phase matrices ⁇ R , ⁇ L are representative of the mean blood flow velocity calculated from the clutter filtered Doppler shift data for the 17 different depths and over the 60 seconds of monitoring, hi the present embodiment, each phase value ⁇ f k , ⁇ f k is calculated from the data for one depth and across 64 pulse-periods.
- the phase matrices ⁇ R , ⁇ L have dimensions of 17 rows by 7,500 columns. Conventional methods can be used to calculate the phase values ⁇ f k , ⁇ f k .
- An example of the Doppler shift data processing is described in more detail in aforementioned U.S. Patent No. 6,196,972 to Moehring.
- a delta follower matrices A R , A L are constructed. That is, a trace aimed at following the background power is calculated.
- the construction of the delta follower array is for eliminating background blood flow signals so that the remaining signals are ETs that are amenable to counting. Conventional methods known to those ordinarily skilled in the art can be used in constructing the delta follower arrays, including the process described in U.S. Patent Nos.
- delta refers to changes in signal power due to the presence of an embolus.
- the delta follower arrays are constructed according to the following rules, which are applied by looping through all values of k for each row j:
- the delta array values A j ⁇ are constructed by determining the absolute difference between the assigned delta values ⁇ J ⁇ and the power values T j k at the current location.
- the step essentially subtracts off background signal (which can be a blood flow signal) from embolic signals:
- the bubble ETs are detected for counting and grading.
- the delta array values A j ⁇ k are tested against a preset threshold to identify a candidate bubble signal B j k at spatial index i and time index j. Once a bubble value is identified, its location and its signal power are stored. The neighboring pixels are interrogated using the same steps to determine the bubble's boundaries. When a candidate bubble is thus isolated, it is subjected to a set of inclusion criteria to be counted as an ET.
- the inclusion criteria are based on a priori information about emboli.
- a candidate bubble signal For example, for a candidate bubble signal to be counted as a bubble ET, it must have a sloping presentation — a change in depth with a change in time — to indicate motion through the vasculature.
- the following three steps are performed inside a loop which searches the ⁇ matrices (A L and A R ) for embolic signals.
- a preliminary test is done to see if the delta matrix value ⁇ exceeds 10 dB for any coordinate pair (j,k) . The first such location discovered is taken to be a candidate bubble signal B JJ ⁇ .
- Steps 1112 and 1114 are performed on the candidate bubble signal B J k and step 1110 is repeated to find the next candidate bubble signal. if ⁇ M > 10
- the set of samples that constitute this candidate bubble signal are then determined by looking for all contiguous samples such that A rJc , > 10.
- the list of values ( /',&') for which ⁇ / ⁇ , > 10 which includes (J, k) and for which there is an accompanying list of ⁇ values, constitutes the candidate bubble list L..
- construction of the candidate bubble list L. is accomplished by using 2-D recursive exploration of matrix samples in the vicinity of (J, k) until values for which ⁇ > 10 are exhausted.
- the candidate bubble list L 1 is constructed for the candidate bubble signal B j k .
- the candidate bubble signal B j k is confirmed or rejected as a bubble
- step 1118 once all the bubbles ETs are identified, the bubble ETs are summed for both channels.
- the grade is then determined, as 0, 1, 2 or 3 according to the conventional six-level manual grading scale previously discussed.
- the grading/counting algorithm of Figure 10 is modified to include an additional algorithm for distinguishing between grade 4 and grade 5.
- the additional algorithm is described with respect to Figure 12.
- the standard deviation of each column of ⁇ ' is calculated to construct a row vector ⁇ having 75 values.
- i 0 indicate the index of the point where 77(I 0 ) ⁇ T 0 ⁇ ⁇ (i 0 + 1)
- Z 1 indicate the first index beyond i 0 where 77(Z 1 ) > T 0 > 77(Z 1 + 1) .
- a shower of grade 5 or higher is reported for the interval between the points i 0 and Z 1 at step 1212. Otherwise, a shower of grade 4 is reported for the interval between the points i 0 and Z 1 at step 1214.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Abstract
Systems and methods for grading signals from microemboli in blood flow monitored using a Doppler ultrasound system. Signals from microemboli in blood flow are graded by calculating a value related to a power for the signals from microemboli in blood flow and categorizing the signals into one of at least two grades based on the calculated value. Alternatively, signals can be categorized by assessing a power value for the microemboli in blood flow during a period of monitoring. In response to the power value being greater than or equal to a threshold value, the microemboli in blood flow are categorized based on the power value, and in response to the power value being less than the threshold value, a number of microemboli are counted during at least a portion of the period of monitoring and the microemboli are categorized based on the number.
Description
SYSTEM AND METHOD FOR GRADING MICROEMBOLI MONITORED BY A MULTI-GATE DOPPLER ULTRASOUND SYSTEM
TECHNICAL FIELD
[001] The invention relates generally to Doppler ultrasound systems, and more particularly, a system and method for grading microemboli, such as ultrasonic contrast agents that move in blood flow, using a multi-gate Doppler ultrasound system.
BACKGROUND OF THE INVENTION
[002] Cryptogenic strokes and transient ischemic attacks ("TIAs") are those in which no obvious cause is found by patient history, carotid Doppler studies, or cardiac conditions such as atrial fibrillation, myocardial infarction, or valve diseases. Patent foramen ovale ("PFO"), which is a small flap-valve hole in the heart, has been associated with cryptogenic stroke allowing paradoxical embolism from the veins to the brain through a right-to-left shunt ("RLS"). Normally, blood returning to the heart from the veins is re-oxygenated when it is pumped from the right side of the heart and then through the lungs. However, in people with PFO, the venous blood, which may contain clots, may instead travel through the hole (i.e., the PFO) between the upper chambers of the heart and into the arterial blood, bypassing the lungs where the clots would normally be filtered out. When this blood goes to the brain, a clot may cause a stroke or stroke- like symptoms. In approximately 40 percent of stroke cases, the underlying cause is difficult to determine and the stroke is called "cryptogenic". Evidence now suggests that when a person has a stroke, and its cause is undetermined, the person is about twice as likely as the normal population to have PFO.
[003] Currently, PFO is considered when stroke occurs in young people. However,
PFO is found in all ages; 34% of adults in the first three decades of life declining to 20% in the 9th and 10th decades and ranging from 1 to 19mm in diameter. Cryptogenic stroke patients, assessed with traditional single gate transcranial Doppler ("sgTCD"), have 12 to 1 odds of having a large PFO compared to a non-stroke group. Also,
migraine patients with aura have a 3 to 1 odds of having a PFO compared to a non- migraine group. Conditions for venous thrombosis and pulmonary embolism also exist widely and deep vein thrombosis is a common finding in the vascular laboratory. Therefore, the conditions for paradoxical embolism are widely prevalent at all ages.
[004] Atrial septal defect ("ASD") is a permanent opening through the interatrial septum that often persists into adulthood. Blood flows back and forth through the defect depending on the back and forth pressure gradient between the atria. This defect usually places a load on the right ventricle that, however, may be tolerated for many years. If the mean right atrial pressure is chronically elevated these patients have a significant desaturation of the arterial blood.
[005] The urgency to diagnose PFO and ASD is driven by the advent of safe transcatheter closure devices and the popularity of TCD over invasive transesophageal echocardiography ("TEE") has enhanced the search for PFO and ASD. sgTCD has demonstrated high accuracy in ruling in, and ruling out, PFO when compared to TEE. . Particularly, sgTCD is able to detect large shunts, which are more clinically relevant. Using intravenous injections of agitated saline, which provide an ultrasonic contrast agent of bubbles, the suspended bubbles pass through the PFO from the right to the left atrium and are easily detected by TCD as audible chirps and microembolic spectra in the cerebral arteries. Agitated saline contrast agent has been used safely for many years in echocardiography and TCD. As known, bubbles in agitated saline do not pass the lungs, and therefore a shunt from the venous system to the arterial system which bypasses the lungs is the only way for bubbles to be seen on the arterial side. A Valsalva strain (forced expiratory effort against a closed glottis) facilitates passage of the microbubbles through the PFO by raising the pressure in the right atrium over that of the left atrium.
[006] TEE is currently considered the "gold standard" for PFO diagnosis. However, it is poorly tolerated by patients and requires deep sedation, which limits the patient's ability to. perform a Valsalva maneuver. sgTCD has proven to be a reliable technique for diagnosing PFO. While PFO diagnosis and treatment are facilitated by TCD's less
invasive technology, sgTCD and TEE are limited by a grading system that uses 3 categories to rate the degree of RLS. Ih patients with ischemic or cryptogenic stroke, the need exists to further quantify RLS.
[007] An improvement over the use of TEE and sgTCD for evaluating PFO is provided by recently developed multi-gate power m-mode TCD (pmTCD) ultrasound devices. An example of such an ultrasound system is the digital Doppler platform developed by Spencer Technologies in Seattle, Washington in which up to 33 sample gates placed at 2 mm intervals can be simultaneously processed into a "color" power m- mode image. The color in the m-mode image is a function of Doppler signature power and detected velocity, in that increases in backscattered power cause the colors, red or blue, to become more intense. Additionally, a spectrogram for a selected depth in the depth range can be displayed. The digital Doppler platform is referred to as Spencer Technologies' Power M-mode Doppler ("PMD"). Showing power in this fashion conveys to the user when the Doppler beam is well aimed — that is, intensity of color increases with volume of moving blood in the Doppler sample volume and this indicates when the beam is centered on the blood flow. Thus, the color m-mode display of an ultrasound system having PMD capability provides medical professionals who do not have expertise in ultrasound with a mechanism for easy location (by the operator) of the middle cerebral circulation. A more detailed description of PMD ultrasound systems can be found in U.S. Patent No. 6,196,972 to Moehring, issued March 6, 2001 and assigned to Spencer Technologies.
[008] In an application evaluating PFO, pmTCD detects 66% more bubble microemboli than traditional sgTCD. The increased detectability allows for use of an expanded six-level grading scale to rate the degree of RLS, in contrast to the three-level grading system provided by TEE and sgTCD. In performing the evaluation of PFO using pmTCD, bilateral monitoring is performed with the beam including the ipsilateral middle cerebral and anterior cerebral arteries ("MCAs") and ("ACAs"). The two probes are positioned bilaterally and stabilized using a head-frame" worn by the patient. The spectrogram sample volumes of the PMD are set near the origin of each respective
MCA at a depth of 50 mm to 60 mm. The PMD is observed for embolic tracks ("ETs") while listening to the MCA spectral signal.
[009] In observing the bubble emboli, pmTCD produces unique signatures of emboli, appearing as brightly colored ETs as they pass through the insonated arteries. When an embolus moves toward the transducer, a bright red upward-sloping ET is produced. In contrast, when an embolus moves away from tiie transducer, a bright blue downward- sloping ET is produced. The sloping feature of the ET is prima facie evidence of an embolus (i.e., a bubble or particle) carried by the blood through a vessel within the ultrasound beam. The slope shows the embolus velocity as a change in depth over time. If the single gate is placed in any of the colored bands, ETs also appear on the spectrogram as high intensity microembolic signals ("MESs").
[010] For PFO evaluation, generally, all ETs are counted in the bilaterally insonated arteries from a depth range of approximately 40 mm to 75 mm. Typically, all ETs and MESs are counted visually. Because the beams overlap at the midline at a depth of 75 mm, ETs are not counted at depths beyond 75 mm. Based on the number of ETs counted, a grade is determined according to following the expanded six-level logarithmic grading scale to rate the degree of RLS: grade 0=0 ETs, grade I = 1-10 ETs, grade II = 11-30 ETs, grade IH = 31-100 ETs, grade IV = 101-300 ETs, and grade V > 300 ETs. The expanded six-level grading scale does not predict the size of the opening, but does provide a measure of the conductance or ability of the opening to transmit material from the venous circulation to the brain. That is, the numbers of ETs represent tracers of the conductance of RLS flow to the anterior circulation of the brain. The conductance takes into account many factors including the RLS flow distribution to the anterior circulation of the brain, the size of the foramen while open, and the right-to- left pressure gradient when the foramen is open. For unilateral pmTCD monitoring, the number of ETs counted are doubled and the resulting number applied to the six-level grading scale accordingly.
[011] The use of pmTCD has provided greater accuracy and an improved grading scale for determining the functional conductance of PFO. However, the process of
visually counting the ETs detected during examination can be time consuming. Thus, immediate grading of PFO for the higher grades is unlikely. Additionally, counting the number of ETs for the higher grades, such as grades 4 and above, is often difficult as visually distinguishing between individual ETs on a PMD monitor for higher grades, that is, those grades having higher number and density of ETs, may not be possible. As a result, the grading process, specifically for PFO, and more generally, for any visual counting or grading process based on the number of ETs, is susceptible to counting errors. Moreover, due to the practical limitations of visually counting individual ETs at higher densities of ETs, further expansion of a grading scale to provide greater grading resolution may not be possible.
SUMMARY OF THE INVENTION
[012] Aspects of the invention include systems and methods for grading signals from microemboli in blood flow that is monitored using a Doppler ultrasound system. In one aspect, the signals from microemboli in blood flow are graded by calculating a value related to a power for the signals from microemboli in blood flow and categorizing the signals from microemboli in blood flow into one of at least two grades based on the calculated value. In another aspect of the invention, categorizing microemboli in blood flow monitored using a Doppler ultrasound system includes assessing a power value for the microemboli in the blood flow during a period of monitoring. In response to the power value being greater than or equal to a threshold value, categorizing the microemboli in blood flow based on the power value, and in response to the power value being less than the threshold value, counting a number of microemboli during at least a portion of the period of monitoring and categorizing the microemboli based on the number.
BRIEF DESCRIPTION OF THE DRAWINGS
[013] Figure 1 is a functional block diagram of a Doppler ultrasound system in which embodiments of the present invention can be implemented.
[014] Figure 2 is a functional block diagram of a portion of a Doppler digital signal processor ("DSP") platform of the Doppler ultrasound system of Figure 1. [015] Figure 3A is a functional block diagram of a transmit circuit of the DSP platform of Figure 2. Figure 3B is a functional block diagram of a receive circuit of the
DSP platform of Figure 2. [016] Figure 4 is a flow diagram for Doppler shift signal processing performed by the
DSP platform of Figure 2. [017] Figure 5 is a flow diagram for a grading algorithm according to an embodiment of the present invention using Doppler shift data from the DSP platform of Figure 2. [018] Figure 6 is a flow diagram for Doppler shift data processing of Figure 5 according to an embodiment of the present invention. [019] Figures 7A-7F are PMD/spectrogram images for various grades of functional conductance of PFO. [020] Figure 8 is a flow diagram for a grading algorithm according to another embodiment of the present invention. [021] Figure 9 is a flow diagram for a grading algorithm according to another embodiment of the present invention. [022] Figure 10 is a flow diagram for a grading algorithm according to another embodiment of the present invention. [023] Figure 11 is a flow diagram for Doppler shift data processing of Figure 10 according to an embodiment of the present invention. [024] Figure 12 is a flow diagram for processing data in Figure 10 according to an alternative embodiment of the present invention.
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
[025] The present invention includes embodiments directed to automatically grading and/or counting embolic signatures detected using a multi-gate Doppler ultrasound system. One embodiment of the present invention, which will be described in more detail below, can be used with a multi-gate pmTCD ultrasound device for grading the
functional conductance of PFO. Alternative embodiments of the present invention can also be used in other applications where grading and/or counting ETs during monitoring cerebral blood flow using pmTCD is desirable, including, monitoring the brain during heart surgery, carotid surgery, orthopedic surgery, or other procedure where significant invasive activity may potentially release emboli returning to the heart in the venous system. Certain details are set forth below to provide a sufficient understanding of the invention. However, it will be clear to one skilled in the art that the invention may be practiced without these particular details. Moreover, the particular embodiments of the present invention described herein are provided by way of example and should not be used to limit the scope of the invention to these particular embodiments. In other instances, well-known circuits, control signals, timing protocols, and software operations have not been shown in detail in order to avoid unnecessarily obscuring the invention.
[026] Figure 1 is a functional block diagram of a multi-gate Doppler ultrasound system 100 in which an embodiment of the present invention can be implemented. The ultrasound system 100 includes a Doppler DSP platform 200 coupled to a probe 112 having an ultrasound transducer 113. The Doppler DSP platform 200 provides for generating transmit waveforms to drive the transducer of the probe 112, digitizing echo signals detected by the transducer 113 of the probe 112, and signal processing to generate Doppler shift data representative of Doppler shift signals extracted from the echo signals.
[027] As shown in Figure 1, a second probe 114 having an ultrasound transducer 115 can also be coupled to the DSP 200 where bilateral monitoring of cerebral blood flow is desirable. The probe 114 can be the same in structure and functionality as the probe 112 previously described. Consequently, a more detailed description of the probe 114 has not been provided herein. When using both the probes 112, 114 for monitoring blood flow, the Doppler DSP platform 200 is further capable of controlling the transmit function of both the probes, as well as process the echo signals detected by the probes 112, 114 in order to generate Doppler shift data representing Doppler shift signals
extracted from the echo signals. In one embodiment, a separate channel is provided for each probe 112, 114. In an alternative embodiment, various circuits are shared between the two channels while other circuits are kept separate. It will be appreciated by those ordinarily skilled in the art that the particular arrangement of the circuits described herein are not intended to limit the scope of the present invention.
[028] The DSP platform 200 is coupled to a processing system 120 through a bus 122.
The bus 122 can be implemented using conventional computer busses and protocols, for example, the bus 122 can be a universal serial bus ("USB"). The processing system 120 is configured for additional processing of Doppler shift data provided by the DSP platform 200. The processing system 120 also provides the DSP platform 200 with, among other things, commands and data for controlling the functions of the DSP platform 200. Additionally, the processing system 120 executes a grading algorithm for grading and/or counting ETs detected by the ultrasound system 100, as described in more detail below. The processing system 120 can be a host computer system to which the DSP platform 200 is coupled, or alternatively, can represent processing systems included with the DSP platform 200, or in an ultrasound system in which the DSP platform 200 is included for standalone Doppler processing.
[029] The processing system 120 is coupled to a display device 126 for providing visual information and feedback to an operator. The information can be displayed in different formats on the display device 126. For example, in a specific application for monitoring cerebral blood flow, blood flow information can be displayed in a PMD format, as described in U.S. Patent No. 6,196,972 to Moehring, which is incorporated herein by reference. The display device 126 can be a conventional display device now known or later developed, including a flat panel display or cathode ray tube ("CRT") display, which can be integrated with the ultrasound system 100, or is a standalone display device connected to the processing system 120.
[030] The processing system 120 is further coupled to a data storage device 130 to store data or retrieve data from external storage media. Examples of typical data storage devices 130 include hard and floppy disks, tape cassettes, compact disk read-
only ("CD-ROMs") and compact disk read-write ("CD-RW") memories, and digital video disks ("DVDs"). The ultrasound system 100 is also coupled to audio speakers 132 for providing audio information, and is further coupled to a microphone 134 for receipt of audible information input by an operator. One or more input devices 136, such as a keyboard or a mouse, are included in the ultrasound system 100 to allow the operator to interface with the ultrasound system 100. Although not shown in Figure 1, the processing system 120 can further include conventional circuits and software for storing the audio and visual information for later playback and viewing. [031] Figure 2 illustrates a portion of the circuits included in the DSP platform 200.
The DSP platform 200 includes a TX/RX/DSP-chamel 201 coupled to the transducer
113 of the probe 112. The TX/RX/DSP-channel 201 includes transmit and receive circuits 210 and 212, respectively, coupled to a DSP 218 through a logic circuit 216. The logic circuit 216 represents a front end processor that is used for performing repetitive tasks in the processing chain and provides a link between the analog front end of the TX/RX/DSP-channel 201 represented by the transmit and receive circuits 210 and 212, and the digital environment of the DSP 218. The TX/RX/DSP-channel 201 is coupled through the data bus 122 to the processing system 120. As previously discussed, the processing system 120 can represent a host computer system, processing systems included with the DSP platform 200, processing systems included in the ultrasound system 100, or some other alternative processing system. Where the probe
114 is used in combination with the probe 112 for bilateral monitoring, as previously discussed, a second TX/RX/DSP-channel (not shown, the same as the TX/RX/DSP- channel 201) can be included in the DSP platform 200.
[032] Figures 3 A and 3B illustrate the transmit circuit 210 and the receive circuit 212, respectively, that are included in the TX/RX/DSP-channel 201 (Figure 2). The transmit and receive circuits 210, 212 are coupled to the ultrasound transducer 113 of the probe 112 to provide transmit and receive functionality, respectively, to the probe 112. With reference to Figure 3 A, the transmit circuit 210 receives control signals from the processing system 120 to control the ultrasound beam delivered by the prove 112. For
example, the control signals provided to the transmit circuit 210 can be used to set gain, carrier frequency, length of the transmit burst and pulse repetition frequency ("PRF"). In one embodiment, the transducer 113 is driven to deliver pulsed ultrasound having a carrier frequency of 2 MHz and a PRF of 8 kHz. The DSP 218 provides the appropriate digital commands to the logic circuit 216 to activate a particular mode (i.e., transmit or receive) of operation. The logic circuit 216 generates two digital logic pulse trains Vl and V2 with the specified carrier frequency (divider applied to external clock), PRF, and pulse length. The two pulse trains Vl and V2 signals are provided to an operational amplifier 220 included in the transmit circuit 210, are added 180 degrees out of phase, and amplified by the operational amplifier 220 according to the gain specified by the control signals from the processing system 120.
[033] The operational amplifier 220 is preferred to provide approximately 40 dB of programmable transmit gain. However, amplifiers having other gain characteristics can be used as well. The specified gain is provided to the logic circuit 216 as digital data, which is converted by a digital-to-analog converter ("DAC") 222 into an analog gain signal applied to the operational amplifier 220. The resulting output signal from the operational amplifier 220 is a square "sinusoid" with center voltage of zero volts. The amplified signal is then applied to the transducer 113 through a tuning circuit (not shown in Figure 3) to drive the transducer 113 to deliver pulsed ultrasound having a pulse period corresponding to the PRF.
[034] With reference to Figure 3B, the receive circuit 212 receives echo signals detected by the transducer 113. The echo signals are provided to a receive amplifier 224. In one embodiment, the amplifier 224 provides a fixed gain of approximately 40 dB and bandpass filtering with a center frequency of 2 MHz and a bandwidth of approximately 300 kHz. Other carrier frequencies and corresponding center frequencies can be used as well. For each pulse period of delivered ultrasound, the amplified and bandpass-filtered echo signals are sampled at four times the carrier frequency by an analog-to-digital converter ("ADC") 226 to provide digital echo data representative of the amplified and bandpass-filtered echo signals. In the present
example, the sampling frequency of 8 MHz based on a carrier frequency of 2 MHz. The echo data are processed by the logic circuit 216 to demodulate the echo signals for a pulse period of ultrasound into Doppler (I, Q) shift samples that stratify the depth range of interest along the ultrasound beam. As known in the art the "I" value represents a measure of a Doppler shift sample along an "in-phase" or "real" axis of the complex plane and the "Q" value represents a measure of the Doppler shift sample at essentially the same time and position, but on a "quadrature" or "imaginary" axis of the complex plane. In addition to the Doppler (I,Q) shift samples, the echo data generated by the ADC 226 are also output by the logic circuit 216. The Doppler (I, Q) shift samples and the echo data generated by the logic circuit 216 are provided to respective DSPs 218 (Figure 2) to construct Doppler shift signals from multiple Doppler shift samples. Each Doppler shift signal is constructed from Doppler shift samples from the same echo depth and across multiple pulse periods. The Doppler shift signals are represented by Doppler shift data that are output by the respective DSPs 218. Figure 9 is a flow diagram illustrating the signal and data processing performed by the DSP platform 200 for echo signals detected by the transducer 113 (Figure 1). The echo signals are amplified and band-pass filtered at the carrier frequency at step 402. The amplified and band-pass filtered echo signals are then digitized to provide digital echo data representing the amplified and band-pass filtered echo signal at step 404. The echo data is demodulated at step 406 to generate Doppler (I5Q) shift samples for the depth range. The Doppler (I5Q) shift signals are low-pass filtered at step 408 to remove noise outside the bandwidth of the transmit signal. Demodulation and low-pass filtering are performed within each pulse period. At step 410, the low-pass filtered Doppler (I5Q) shift samples are decimated to carry forward only candidate signals from the depth or depth range of interest. Doppler shift signals represented by Doppler shift data are constructed at step 410 from the Doppler (I5Q) shift samples from multiple pulse periods. The Doppler shift signals are clutter filtered at step 412 to suppress "clutter" from each Doppler shift signal. With reference to Figure 2, steps 402-412 are generally performed by the DSP platform 200.
[036] Suitable methods for demodulating, low-pass filtering and decimating are described in greater detail in the aforementioned U.S. Patent No. 6,196,972 to Moehring. However, it will be appreciated that other methods can be used as well. In summary, the aforementioned patent describes a demodulation process for generating Doppler (I3Q) shift samples that can be performed through simple subtraction operations operating on each successive quartet of samples of echo data for a pulse period. Each sample corresponds to digital echo data resulting from sampling the signal output by the receive amplifier 224 at four-times the carrier frequency. For a quartet of samples, the third value is subtracted from the first value to produce the real part "I" and the second value is subtracted from the fourth value to produce the imaginary part "Q" of a complex Doppler (I,Q) shift sample for an associated depth. The same operation is performed on all quartets of samples of echo data for a pulse period, with each succeeding quartet of points associated with a location of greater depth. The particular demodulation method blurs the axial resolution by approximately one wavelength of the carrier, but is acceptable in typical applications since one wavelength of the carrier is inconsequential relative to the typical sample volume size associated with medical pulse Doppler ultrasound.
[037] Demodulation into Doppler (I5Q) shift samples is followed by a low-pass filter operation. The low-pass filter operation described in the aforementioned patent involves taking as many as 35 contiguous gate positions bracketing a desired gate depth, within one pulse period, and applying a low-pass finite impulse response ("FIR") filter. The process of low-pass filtering reduces out-of-band noise from a signal which is sampled across successive pulses at a relatively low frequency (i.e., at the PRF). The FIR filter is applied to the Doppler (I,Q) shift samples spanning the depth range bracketing a gate to construct one Doppler (I, Q) shift sample for each particular gate for the particular pulse period.
[038] Clutter cancellation can be accomplished with infinite impulse response ("HR") filters, as described in detailed in the aforementioned U.S. Patent No. 6,196,972 to Moehring. However, other clutter cancellation filters can be used as well. The clutter
filtered Doppler shift data is then provided to the processing system 120 from the DSP platform 200 where it further processed. For example, the data can be processed by the processing system 120 to construct a PMD image for display on the display 126 (Figure 1) to provide visual feedback to an operator regarding blood flow in a region interrogated by ultrasound. Although not discussed herein in detail, construction of an image from the Doppler shift data can be accomplished using conventional techniques now known by those ordinarily skilled in the art, for example, as described in the aforementioned U.S. Patent No. 6,196,972 to Moehring, or later developed. Consequently, in the interest of brevity, a detailed discussion of constructing such an image is omitted from herein.
[039] As previously mentioned, and as will be explained in more detail below, the
Doppler shift data provided by the DSP platform 200 can be further processed in order to grade and/or count MESs detected using the ultrasound system 100. The particular embodiment described below is directed to grading functional conductance of PFO according to various grading scales. However, as previously mentioned, alternative embodiments of the present invention can be utilized in other applications as well. From the description provided herein, those ordinarily skilled in the art will obtain sufficient understanding to practice the invention in various applications, and consequently, the scope of the invention should not be limited to the particular embodiments described herein.
[040] Figure 5 is a flowchart for an algorithm that performs automatic grading of the functional conductance of a PFO. The embolic signatures evaluated by the algorithm are bubbles injected into a patient in accordance with a conventional protocol for evaluating PFO in the patient. In one embodiment, the contrast bubble ETs are . monitored following the release of the Valsalva maneuver and continues for a time period thereafter. At step 502, the Doppler shift data provided by the DSP platform 200 (Figure 1) is processed to calculate a value related to the energy of bubble ETs detected following the release of the Valsalva maneuver and during the subsequent monitoring period.
[041] Based on the value calculated, the functional conductance of the PFO is graded according to a grading scale that generally corresponds to a conventional six-level logarithmic scale that is typically used for PFO evaluation based on visually counting bubble ETs detected by a multi-gate pmTCD ultrasound device. The conventional six- level logarithmic grading scale is as follows:
[042] Grade 0 = 0 ETs,
[043] Grade I = 1-10 ETs,
[044] Grade II = 11 - 30 ETs,
[045] Grade HI = 31 - 100 ETs,
[046] Grade TV = 101 - 300 ETs, and
[047] Grade V = > 300 ETs.
[048] In contrast, the grading scale used in the present embodiment of the invention has seven grades that generally correspond to the conventional grading scale. More specifically, the seven grades are: Grade 0, Grade 1, Grade 2, Grade 3, Grade 4, Grade 5, and Grade 5+ (5+ is distinguished from 5 in that it has at least a two heart cycle period during which there is a homogenous white-out of the spectrum and the m-mode display. The algorithm performs grading at steps 504-516 by comparing the value calculated at step 502 to respective threshold values defining the different grades. The values used for the thresholds will be discussed in more detail below.
[049] hi contrast to visually counting the number of bubble ETs, in the present embodiment the energy associated with the bubble emboli is quantified and compared to energy thresholds. Based on the comparison, a grade for the functional conductance of the PFO is made. The grade provided by the algorithm constitutes a finding which informs a physician who will interpret the finding, come to a diagnosis, and determine appropriate clinical management based on the diagnosis. By using the algorithm shown in Figure 5, having a technician visually count the number of bubble ETs is unnecessary. As a result, the grading performed by the algorithm is less prone to errors, and additionally, can provide a grade much faster than using the conventional method.
[050] Figure 6 is a flowchart that illustrates in greater detail the processing of the
Doppler shift data of step 502 (Figure 5). Matrices will be identified herein by a variable, and entries in a matrix are identified by indices j and k , where j represents a row index and k represents a column index, as known. For example, a matrix Q has a dimension of M rows and N columns. The entries in the matrix Q are identified by QJιk , where j = 1 to M and k = 1 to N . Additionally, where matrices are constructed for each of the channels, the respective matrix is identified by "R" for the right channel and "L" for the left channel. For example, the matrix Q for the right channel is identified as QR and the matrix Q for the right channel is identified as QL .
[051] At step 602, matrices BR and BL of background Doppler signal power data are constructed from Doppler shift data acquired from the left and right channels. In one embodiment, the Doppler signal power is calculated for a period of 10 seconds during normal respiration by the patient, however, time periods other than 10 seconds can be used as well. Assuming that the ultrasound delivered to the patient has a PRF of 8 kHz, and the Doppler shift signal power is calculated using 64 pulse periods (i.e., a Doppler shift signal power value is calculated every 8 ms), 1,250 Doppler shift signal power values are calculated over the 10 seconds of monitoring. Calculating Doppler signal power from the Doppler shift data is known in the art, and consequently, in the interest of brevity, will not be described in detail herein. Using a typical depth range of 44-76 mm, with 2 mm intervals, for monitoring the MCA and ACA results in 17 different depths. Thus, the resulting matrices BR , BL for the right and left channels, respectively, have dimensions of 17 rows by 1,250 columns.
[052] At step 604, matrices SR and SL of signal power data are constructed from
Doppler shift data acquired from the left and right channels shortly after the release of the Valsalva maneuver. In one embodiment, the Doppler signal power is calculated for a period of 60 seconds, although in other embodiments different time periods can be used. For 60 seconds of Doppler shift signal power, a matrix of 17 rows by 7,500 columns of Doppler shift signal power is constructed for each channel. The 17 rows
represent 17 different depths over the depth range of 44-76 mm in 2 mm gate intervals, and the 7,500 columns represent the number of Doppler shift signal power values calculated over the 60 seconds, each value calculated from 64 pulse periods of ultrasound having a PRF of 8 kHz.
[053] Using the matrices BR , BL , SR and SL , two signal-to-background ratio matrices TR and TL are constructed at step 606. Each of the matrices is constructed by dividing all Doppler shift signal power values SR tk , Sj>k in a row of the signal matrix SR , SL by a mean Doppler Shift signal power ("mean background power vector," Z. ) calculated from the Doppler shift signal power values Bj k , Bjk in the corresponding row of the corresponding (i.e., left or right channel) background matrix BR , BL . The resulting mean background power vectors Z3 define a mean background power matrix for each channel, ZR and ZL . Each matrix ZR , ZL has dimensions of 17 rows and 1 column. The 17 rows correspond to the 17 different depths and the 1 column corresponds to a respective mean background power vector at each of the 17 depths. The two resulting matrices (i.e., left and right channels) of signal-to-background ratios TR, TL have dimensions of 17 rows by 7,500 columns. Although in the present embodiment a mean background power value is calculated, a median power value can be alternatively used in calculating the values TR k , τ£k for the matrices of signal-to- background ratios TR , TL .
Σ BJ* where, B. = — —
[055] At step 608, a beam power analysis is performed for each channel. Using the median background power vectors Zj in the matrices ZR and ZL , the vectors are
summed from each channel to provide to values PR and PL corresponding to the beam power for each of the channels. The values PR and PL are expressed in terms of decibels.
M
P = IOlOg10C]TZ,.) [056] M J (0.2)
Where, Z, - median(Bj k)
[057] At step 610, the signal-to-background ratios Tfk, Tf k of the matrices TR , TL are converted into decibels, and result in two matrices VR and VL .
[058] F^ = IOlOg10T7,, (0.3)
[059] At step 612, the matrices VR and VL are analyzed to determine which of the signal-to-background ratios (in dB) likely correspond to a bubble embolic signature. In the present embodiment, every signal-to-background ratio Vfk , Vf k of the matrices VR and VL exceeding a factor of 10 is considered to be a likely candidate corresponding to a. bubble signal. The results of the determination are used to construct two binary bubble signal matrices βR and βL (i.e., one for the right channel and one for the left channel). Each binary matrix βR, βι includes binary values βR k , β)k ("1" or "0") arranged in 17 rows and 7,500 columns. Each "1" indicates that the signal-to- background ratio Vfk , Vf k for the corresponding location in the matrix of signal-to- background ratios VR , VL exceeded a factor of 10 and each "0" indicates that the signal-to-background ratio Vfk , Vf k for the corresponding location in the matrix of signal-to-background ratios VR , VL did not exceed a factor of 10. At step 614, filtered bubble signal matrices FR and F1 are constructed for each channel by multiplying the signal matrices VR and VL (in dB) with the binary matrices βR , βL .
[060] where (0.4)
[061] Each, of the matrices FR and FL have dimensions of 17 rows by 7,500 columns. At step 616, linear domain bubble matrices DR and DL are constructed for each channel by converting the values FR k , FfΛ of the filtered bubble signal matrices FR and FL into the linear domain from the decibel domain.
F ■j1,k/
[062] DJ k = l0 /w (0.5)
[063] At step 618, cross correlation of each one-half second interval with the following one-half second interval is performed. Although the "magnitude" or severity of the bubble embolic signatures could be determine by summing the energy of the isolated bubble signals from the linear domain bubbles matrices DR and DL , the backscatter from bubbles which have a size distribution much smaller than a millimeter will fall into the Raleigh scattering region for 2 MHz ultrasound (λ = 780//). As known, in this scattering region the acoustic backscatter will vary as the 6th power of the diameter of the bubbles. As a result, there can be significant variation in bubble backscatter represented by the signals (and the addition of these signals) of the matrices DR and DL . Consequently, an approach that extracts a shower description parameter from the matrices DR , DL based on a cross correlation is utilized.
[064] Each of the matrices DR and DL are divided into sets of overlapping sub- matrices having dimensions of 17 rows and 128 columns. Each of the sub-matrices roughly represents data for 17 different depths over approximately a one second period, hi the present embodiment, the overlap between adjacent sub-matrices is 50%. A matrix A(i) is defined having the first 64 columns in a given sub-matrix (dimensions M = 17 rows by Nn = 64 columns), where i denotes the index of the sub-matrix. As a
result, there are Ho = IrTt(N5 ZAfJ -I sub-matrices in 60 seconds of data. Similarly, matrix B(i) is defined having the last 64 columns of the same sub-matrix, where i denotes the particular sub-matrix. The algorithm calculates and integrates a correlative vector, R. , for each of the sub-matrices, and thereby formulate a vector CR , CL for each channel as follows ( C has dimensions 1 x 116):
[066] CR , CL axe referred to as "bubble vectors" because they are primary indicators of when bubble shower activity is occurring across the 60 seconds following bubble injection for PFO detection. The amplitude of the individual bubbles towards the magnitude of CR , CL is somewhat softened compared to the amplitude contributions towards directly summing the signals in matrices DR , DL . Bubbles that do not have neighboring bubbles do not make as strong a contribution as bubbles with nearby neighbors.
[067] At step 620, a shower index is calculated. The CR , CL vectors are summed and converted to decibels to give two floating point values ZR and ZL corresponding to the bubble values in the two channels.
[069] The particular autocorrelation measure increases with the intensity of bubble showers and with duration of bubble showers. The operation results in a parameter for sorting high grade showers from low grade showers. At step 622, the shower indices ZR and ZL are weighted according to their beam values to produce a weighted shower index H.
[070] Where, (0.8) abs{PL -PR)
J /-1
[071] The weighted shower index H is the value that is used for grading the functional conductance of Hie PFO. In one embodiment, a seven-level grading scale is used for the functional conductance of the PFO.
[073] With reference to Figure 5, the first threshold from step 504 is 125 dB, the second threshold from step 506 is 110 dB, the third threshold from step 508 is 100 dB, the fourth threshold from step 510 is 80 dB, the fifth threshold from step 512 is 60 dB, and the sixth threshold from step 514 is 40 dB. Other embodiments of the invention can use different threshold values. The threshold values have been provided herein by way of example. Alternative embodiments of the present invention can use different threshold values, and additionally, other alternative embodiments can use greater or fewer grade levels than that previously described.
[074] Figures 7A-7F are a series of PMD/spectrogram images for different patients of a study that included 200 patients for which data was gathered. There was some overlap with the patient population noted in Spencer et al., Power M-Mode Transcranial Doppler for Diagnosis of Patent Foramen Ovale and Assessing Transcatheter Closure, J Neuroimaging 2004; 14:342-349. The PMD/spectrogram images of Figures 7A-7F are taken over a four second period following the release of the Valsalva maneuver. The
images correspond to the different shower grades of the seven-level grading scale, as previously mentioned, where grades are assigned as follows: grade 0 = no emboli ("null hypothesis" is not shown in Figure), grade 1 = 1-10 emboli (Figure 7A), grade 2 = 11-30 emboli (Figure 7B), grade 3 - 31-100 emboli (Figure 7C)3 grade 4 = 101-300 emboli (Figure 7D), grade 5 = in excess of 300 emboli (Figure 7E), and grade 5+ = "white out" for at least two cardiac cycles (Figure 7F). Although Figures 7A-7F illustrate four second periods, the grading, as previously discussed, is based on the number of embolus visually counted over a 60 second period of monitoring. As illustrated in Figures 7A-7C, individual ETs, which appear in the images as vertical streaks in both the PMD and spectrogram images, are easily appreciated for grades 1, 2 and 3. The emboli that make it across the shunt are generally distributed across time sufficiently to allow for individual discrimination. However, counting individual emboli becomes more problematic when considering grades 4, 5 and 5+. As can be seen in Figures 7D-7F, the ETs for these higher grades begin to blend together in a way that is explained by the presence of multiple emboli in proximity to the ultrasound beam at any given time. Counting emboli in this context is difficult given the axial resolution limitation of the ultrasound beam as well as the limited patience of the ultrasound technologist, and therefore a different way to grade these larger "uncountable" showers is desirable. When emboli are countable, on the other hand, as in the lower Spencer grades (1-3), then detecting them individually is feasible with a machine algorithm. The analysis described below was performed retrospectively on data acquired from 200 patients undergoing PFO diagnostic examination with PMD. The analysis was comprised of "training" an algorithm in a set of 100 patients and then re-evaluating its performance in a second set of 100 patients. Instrumentation. A TCD IOOM digital 2-MHz Doppler platform (Spencer
Technologies, Seattle, WA) was used in all exams. The TCD IOOM platform has 33 gates placed at 2 mm intervals along the ultrasound beam. The M-mode display covers a depth range of 25-85 mm and there is an accompanying spectrogram which presents spectral analysis of a user-selected depth in the M-mode display. The insonation
method for this equipment has been described in Moehring et al., Power M-Mode Doppler (PMD) For Observing Cerebral Blood Flow and Tracking Emboli, Ultrasound in Med. & Biol, Vol. 28, No. 1, pp. 49-57, 2002. The ultrasound beam can observe the proximal MCA and the proximal ACA concurrently in most patients. Bilateral monitoring was performed with each probe held in place over a temporal bone by a Marc 600 head frame (Spencer Technologies, Seattle, WA). An MCA gate was selected for each spectrogram. A computer hard disk provided continuous recording that was replayed for manual counting bubble embolic signals, and then used in training the automatic grading algorithm.
[076] Embolic Criteria. The standard for MESs on the sgTCD has been previously defined by an international consensus group in Ringelstein et al., Consensus On Microembolus Detection By TCD, Stroke 1998;29:725-729. However, as previously mentioned, pmTCD produces unique signatures of emboli, appearing as brightly colored ETs as they pass through the insonated arteries. These tracks are more fully described in the Moehring et al. article, and additionally, U.S. Patent Nos. 6,547,736 to Moehring et al., which is incorporated herein by reference. As described therein, when an embolus moves toward the transducer, a bright red upward-sloping ET is produced. Ih contrast, when an embolus moves away from the transducer, a bright blue downward-sloping ET is produced. The sloping feature of the ET is prima facie evidence of an embolus (i.e. a bubble or particle) carried by the blood through a vessel within the ultrasound beam. The slope shows the embolus velocity as a change in depth over time. If the single gate is placed in any of the colored bands, ETs also appear on the spectrogram as spectral MESs. In the study, the ETs in the bilaterally insonated arteries from a depth of 46 mm to 76 mm were used for grading — both automatic and manual — since there is a beam overlap with the beam from the opposite side of the head at the midline (i.e., a depth of 75 mm).
[077] Patient population. A single-group, descriptive study was conducted to evaluate the accuracy of the automated grading algorithm for diagnosing PFO. Non- probability consecutive sampling technique was used to enroll 200 patients referred to
the Spencer Vascular clinic from June 2003 to November 2003. These patients were referred due to re-current ischemic stroke (n = 75, 37.5%) or transient ischemic attack related to presumed paradoxical embolism (n = 18, 9%) or active recurrent migraine (n = 71, 35.5%) or stroke like symptoms (n = 54, 27%), Divers (n = 4, 2%). All 200 patients underwent a pmTCD examination evaluation of PFO prior to the analysis presented herein. Patients were precluded from this study if the probe position changed or patient was talking or snoring or there were bruits or high velocity jets in the gathered data during the course of their pmTCD examination evaluation. The sample ranged in age from 16 to 86 years with a mean of 55 years and a male to female ratio of 0.37:0.63. All examinations were performed in response to referrals by attending physicians, and all patients signed informed consent to use their data in scientific publications. Bilateral temporal bone ultrasound windows were identified in all patients except for 3 females (1.5%) and 1 male (0.5%) who were 81, 49, 77 and 78 years of age. In these four patients, unilateral TCD monitoring was performed and the embolic assessments were essentially multiplied by two to obtain bilateral results. [078] Testing procedure. The Spencer PFO protocol was followed for all the patients in the study, which is a superset of the patients studied in the Spencer et al. article. A minimum of 2 contrast bolus injections were agitated and administered antecubitally (arm vein) while the patient was in recumbent position. The first injection was performed during normal respiration and the second performed immediately prior to a calibrated Valsalva. As suggested in Spencer et al. article, the best results are obtained when a Valsalva is performed during bubble injection. Only the data associated with Valsalva was used in developing the automatic grading algorithm according to the previously described embodiment. However, those ordinarily skilled in the art will appreciate that in procedures such as open heart surgery, the Valsalva is irrelevant to detecting and grading embolic showers, and therefore, embodiments of the present invention are not limited to obtaining data from a protocol that includes a Valsalva maneuver.
[079] Manual Grading Procedure. The conventional RLS conductance grading system has been described in detail in the Spencer et al. article, as well as described herein. The conventional six-level logarithmic scale previously described was used to grade RLS conductance for both the resting and Valsalva injections. Specifically: grade 0 = 0 ETs, grade I = 1-10 ETs, grade E = 11-30 ETs, grade III = 31-100 ETs, grade IV = 101-300 ETs, and grade V > 300 ETs.
[080] Automated grading procedure. As previously discussed, a modified version of the Spencer RLS conductance grading system was used. More specifically, instead of a six-level grading system of 0-5, a seven-level grading system of 0-5+ was used. As in the conventional RLS conductance grading system, only the ETs in the bilaterally insonated arteries from a depth of 46 mm to 76 mm were used for grading since there is a beam overlap at the midline at a depth of 75 mm. As previously described, the Valsalva data is initially normalized using a background signal collected prior to the Valsalva injection. This allows isolation of the ETs from the background blood flow. A numerical method is then used to quantify the ET power intensities.
[081] Assumptions regarding protocol. The following assumptions are made for the protocol in acquiring the data:
[082] 1. STATIONARY PROBE. The probe is positioned with a blood flow signal in view, and the probe position does not change over the entire exam. Signals which indicate probe motions are excluded from grading analysis.
[083] 2. NORMAL FLOW. Signals which indicate bruits (e.g., vessel wall vibrations due to pathology such as stenosis or spasm) or high velocity jets in the gathered data, which by their nature will confound power assessments associated with bubble injections, are excluded from grading analysis.
[084] 3. No SNORING/TALKING. Signals indicative of talking or snoring during the course of the exam are excluded from grading analysis.
[085] Separation of significant PFO (G>=4) from PFO of lesser conductance grades
(G<4) was performed by automatic grading and compared to technologist performance for the training group of 100 subjects. Against the conventional process of having a
technologist manually count the bubble ETs, the automatic grading algorithm had 94% sensitivity, 92% specificity, 8% false positive rate and 6% false negative rate (pO.0001) for the training group. Similarly, detection of conductance grade range G>=4 was performed in the test group with 96% sensitivity, 96% specificity, 4% false positive rate and 4% false negative rate (p<0.0001).
[086] The results of the analysis suggests another embodiment of the present invention, where the algorithm for automatic grading of the functional conductance of a PFO, described with reference to Figure 5, is modified from the seven-level grading scale to a simplified three-level grading scale, as shown in Figure 8. In contrast to the automatic grading of Figure 5, the grading algorithm of Figure 8 uses the value calculated from the Doppler shift data processing of Figure 6 to determine whether there is a null result (steps 804 and 805), a grade lower than grade 4 (steps 806 and 807), or a grade of grade 4 or higher (steps 806 and 808). As with the information provided by the automatic grading algorithm of Figure 5, the information provided by the automatic grading algorithm of Figure 8 constitutes a finding which informs a physician who will interpret the finding, come to a diagnosis, and determine appropriate clinical management based on the diagnosis.
[087] Figure 9 illustrates a grading algorithm according to another embodiment of the present invention. As with the grading algorithm shown in Figure 8, the algorithm of Figure 9 uses a simplified three-level grading scale. However, in contrasts to Figure 8, the grading algorithm of Figure 9 uses the value calculated from the Doppler shift data processing of Figure 6 to determine whether there is a null result (steps 904 and 905), a grade lower than grade 3 (steps 906 and 907), or a grade of grade 3 or higher (steps 906 and 908). As illustrated by the automatic grading algorithms of Figures 5, 8, and 9, the value calculated by the Doppler shift data processing can be used in grading scales having different grade levels.
[088] The previously discussed embodiments of algorithms for automatic grading of embolic signatures, which were directed to grading the functional conductance of a PFO, used a value that quantified the energy associated with the bubble emboli and is
compared to energy thresholds in determining a grade. In alternative embodiments of the present invention, quantifying the energy associated with embolic signatures can be combined with an algorithm that identifies and "counts" ETs. As with the previously described embodiments, the present embodiment will be described with respect to the specific application of grading the functional conductance of a PFO.
[089] Figure 10 is a flow chart of a grading/counting algorithm according to an embodiment of the invention for MESs that are monitored using a multi-gate Doppler ultrasound system. The algorithm shown in Figure 10 uses a six-level grading scale, with grades 0-5. As will be described in more detail below, the algorithm combines quantification of the energy associated with the bubble emboli and automatic identification and counting of ETs.
[090] At step 1002, the Doppler shift data is processed to calculate a first value related to the bubble ETs that are detected following the release of the Valsalva maneuver and during the subsequent time period of monitoring. In the present embodiment, the first value represents the energy associated with the bubble emboli. The process described with reference to Figure 6 can be used to calculate the first value. At step 1004, the first value is compared to a first threshold value. Ih the present embodiment, the first threshold value corresponds to the energy threshold for a grade 4 according to the modified seven-level grading scale previously discussed, that is, 100 dB. If the first value is greater than 100 dB, another comparison is made at step 1006 to the energy threshold for grade 5, which has been previously described as being 110 dB. A grade 5 is reported at step 1008 in the event the first value from step 1002 is greater than 110 dB, and a grade 4 is reported at step 1010 otherwise.
[091] At step 1004, if the first value calculated at step 1002 is less than 100 dB, the
Doppler shift data collected from monitoring the bubble emboli following the release of the Valsalva maneuver is further processed at step 1012 to provide a second value. The second value generally corresponds to the number of ETs that are identified as bubbles over a time period of analysis. In one embodiment, the second value is compared at ' step 1014 to a threshold value that corresponds to the grade 3 threshold of the
conventional six-level Spencer RLS conductance grading scale, in particular, 31 ETs. A grade 3 is reported at step 1014 if the second value is greater than 31. However, in the event the second value is not greater than 31, the second value is compared to a threshold value corresponding to the grade 2 threshold at step 1018, that is, 11 ETs, and is reported as a grade 2 at step 1020 if the number of bubble ETs detected is greater than 11. At steps 1022, 1024, and 1026, if the second value is not greater than 11, then a grade of 1 or a null result is reported at steps 1024 and 1026, respectively, depending on the comparison of the second value at step 1022 to a threshold value that corresponds to a grade 1 threshold, namely, 1 ET. The grade provided by the automatic . grading/counting algorithm of Figure 10 constitutes a finding which informs a physician who will interpret the finding, come to a diagnosis, and determine appropriate clinical management based on the diagnosis.
[092] The particular embodiment of the automatic grading/counting algorithm illustrated in Figure 10 uses an energy value for the bubble ETs in making a determination between reporting a grade 5 or grade 4. For grades less than grade 4, however, the number of bubble ETs detected over the period of evaluation is used to make the grade. The particular details of the automatic grading/counting algorithm of Figure 10 can be modified to provide alternative embodiments. For example, the energy value provided by step 1002 can be used to make a determination between grades higher than a grade 3, and the count value provided by the processing of step 1012 can be used to make a determination for grades lower than grade 3. In another embodiment, not all of the grades between 0 and 5, or 5+, need to be represented. That is, the energy value can be used to determine only if the grade is higher than a grade 4, and if not, identification of a specific grade of 3 or lower can be made using the count value from step 1012. Such modifications are well within the knowledge of those ordinarily skilled in the art, and consequently, will obtain sufficient understanding to practice the various embodiments of the invention from the description provided herein.
[093] Figure 11 is a flowchart for Doppler shift data processing at step 1012
(Figure 10) according to an embodiment of the present invention. The Doppler shift
data is further processed to take advantage of the fact that the bubble embolic showers have "countable" ETs, and can be used to produce a count from which the PFO grade for a grade lower than grade 4 can be directly determined. At step 1102, the TR and TL matrices of signal-to-background ratios TR k , Tf k constructed at step 1002 (Figure 10) are processed to construct median power matrices MR , ML . For each of the 17 rows of signal-to-background ratios TR k, Tfk a median power value is calculated and represents an entry Mf , Mf in the median power matrices MR , M1. Each of the MR , ML matrices have a dimension of 17 rows and 1 column. [094] Mj = median(TJλ) . . (0.10)
[095] At step 1104, the Doppler shift data is processed to construct phase matrices φR , φL having phase entries φfk, φfk. The phase matrices φR , φL are representative of the mean blood flow velocity calculated from the clutter filtered Doppler shift data for the 17 different depths and over the 60 seconds of monitoring, hi the present embodiment, each phase value φfk, φfk is calculated from the data for one depth and across 64 pulse-periods. As a result, the phase matrices φR , φL have dimensions of 17 rows by 7,500 columns. Conventional methods can be used to calculate the phase values φfk , φfk . An example of the Doppler shift data processing is described in more detail in aforementioned U.S. Patent No. 6,196,972 to Moehring. [096] At step 1106, a phase-based correction to the power values is performed. The
TC power value for any data point with a phase less than — (approximately 7 cm/s) is
replaced with the median power value Mf , Mf for that gate depth. The correction in essence fills in a median power value where the background has been filtered away with clutter cancellation filtering. The expression for the phase correction is:
then T]Jk = Mj [098] At step 1108, a delta follower matrices AR , AL are constructed. That is, a trace aimed at following the background power is calculated. The construction of the delta follower array is for eliminating background blood flow signals so that the remaining signals are ETs that are amenable to counting. Conventional methods known to those ordinarily skilled in the art can be used in constructing the delta follower arrays, including the process described in U.S. Patent Nos. 6,547,736 to Moehring et at The "delta" refers to changes in signal power due to the presence of an embolus. The delta follower arrays are constructed according to the following rules, which are applied by looping through all values of k for each row j:
3U = 3Lk-I
[0100] The delta array values AjΛ are constructed by determining the absolute difference between the assigned delta values δJΛ and the power values Tj k at the current location. The step essentially subtracts off background signal (which can be a blood flow signal) from embolic signals:
[0102] At steps 1110-1118, the bubble ETs are detected for counting and grading. The delta array values Ajιk are tested against a preset threshold to identify a candidate bubble signal Bj k at spatial index i and time index j. Once a bubble value is identified, its location and its signal power are stored. The neighboring pixels are interrogated using the same steps to determine the bubble's boundaries. When a candidate bubble is thus isolated, it is subjected to a set of inclusion criteria to be counted as an ET. The
inclusion criteria are based on a priori information about emboli. For example, for a candidate bubble signal to be counted as a bubble ET, it must have a sloping presentation — a change in depth with a change in time — to indicate motion through the vasculature. The following three steps are performed inside a loop which searches the Δ matrices (AL and AR ) for embolic signals. [0103] At step 1110 a preliminary test is done to see if the delta matrix value Δ^ exceeds 10 dB for any coordinate pair (j,k) . The first such location discovered is taken to be a candidate bubble signal BJJζ . Steps 1112 and 1114 are performed on the candidate bubble signal BJ k and step 1110 is repeated to find the next candidate bubble signal. if ΔM > 10
[0104] then BJΛ = AJ k (0.14) else no bubble candidate at location j,k
[0105] At step 1112, once a candidate bubble signal BJ k is identified, its j,k coordinates are stored in a candidate bubble list L. = {J,k} . The set of samples that constitute this candidate bubble signal are then determined by looking for all contiguous samples such that ArJc, > 10. The list of values ( /',&') for which Δ/ έ, > 10 , which includes (J, k) and for which there is an accompanying list of Δ values, constitutes the candidate bubble list L.. In the present example, construction of the candidate bubble list L. is accomplished by using 2-D recursive exploration of matrix samples in the vicinity of (J, k) until values for which Δ > 10 are exhausted. However, other methods of constructing the candidate bubble list L1 can be used as well. Once the candidate bubble list L1 and associated power values are extracted, all these locations in the source matrix Δ are set to a background power value to guarantee that they are not rediscovered through a subsequent recursive search when finding the "next" candidate signal in step 1110.
[0106] At step 1114, after the candidate bubble list L1 is constructed for the candidate bubble signal Bj k , the candidate bubble signal Bj k is confirmed or rejected as a bubble
ET based on the following criteria: [0107] (1) Size: the total number of coordinate pairs in the candidate bubble list L1 must be between 10 and 200.
[0108] (2) Slope: a linear regression is performed on the coordinate pairs in the candidate bubble list L1 to calculate the slope. The calculated slope is expected to be greater than 70 but less than 2000 (these are unit-less ratios of indices) to be considered a bubble.
[0109] The previously described criteria for confirming or rejecting a candidate bubble signal Bj k as a bubble ET has been provided by way of example. Other rules or criteria can be used as well. For example, a simplistic surrogate for the slope requirement might be requiring that the coordinate set span a fixed number of rows and columns. More generally, the specific example provided herein is intended to demonstrate that a priori information about emboli of interest moving in blood flow for a given application or vessel can be used in a grading/counting algorithm at these steps in the algorithm to maximize specificity for the embolic phenomena of interest.
[0110] At step 1118, once all the bubbles ETs are identified, the bubble ETs are summed for both channels. The grade is then determined, as 0, 1, 2 or 3 according to the conventional six-level manual grading scale previously discussed.
[0111] In an alternative embodiment, the grading/counting algorithm of Figure 10 is modified to include an additional algorithm for distinguishing between grade 4 and grade 5. The additional algorithm is described with respect to Figure 12. At step 1202, the delta follower matrices AL , AR constructed at step 1108 (Figure 11) are re- segmented into a series of non-overlapping windows which have size of m0 = 17 rows and Tn1 = 100 columns. This is accomplished by taking the total number of columns in the AL, AR matrices and dividing by m2 = 75 to get the number of columns, W1 = 100, in each non-overlapping sub-matrix. Each sub-matrix is reshaped into a column* vector
with the same number of total points of m0 • Tn1 = 1,700. The mx = 100 resulting column vectors in a given sub-matrix are concatenated, to build a matrix Δ1 having TO0 • n\ = 1,700 rows and m2 = 75 columns for each channel.
[0112] At step 1204, the standard deviation of each column of Δ' is calculated to construct a row vector η having 75 values. At step 1206, the domains of the signal η for which the signal exceeds a threshold of T0 = 5 are found. Let i0 indicate the index of the point where 77(I0) < T0 < η(i0 + 1) , and Z1 indicate the first index beyond i0 where 77(Z1) > T0 > 77(Z1 + 1) . At step 1208, the number of slices in the shower interval is equal to M3 = (I1 - i0 + I) - Tn1. At steps 1210, if m3 > T1 where T1 = 750 slices, then a shower of grade 5 or higher is reported for the interval between the points i0 and Z1 at step 1212. Otherwise, a shower of grade 4 is reported for the interval between the points i0 and Z1 at step 1214.
[0113] From the foregoing it will be appreciated that, although specific embodiments of the invention have been described herein for purposes of illustration, various modifications may be made without deviating from the spirit and scope of the invention. Accordingly, the invention is not limited except as by the appended claims.
Claims
1. A method for grading signals from microemboli in blood flow, the blood flow monitored using a Doppler ultrasound system, the method comprising: calculating a value related to a power for the signals from microemboli in blood flow; and categorizing the signals from microemboli in blood flow into one of at least two grades based on the calculated value.
2. The method of claim 1, further comprises acquiring signals from microemboli in blood flow by: for a period of monitoring and a background period, extracting Doppler shift signals from echo signals resulting from ultrasound delivered to a region in which blood flow is detected; calculating signal-to-background data from the Doppler shift signals from the period of monitoring and the background period; and determining from the signal-to-background data the presence of microemboli in the blood flow during the period of monitoring.
3. The method of claim 2 wherein calculating signal-torbackground data from the Doppler shift signals comprises: calculating mean background power for a depth range from the Doppler shift signals from the background period; calculating Doppler signal power values for the depth range over the period of monitoring from the Doppler shift signals from the period of monitoring; and dividing the Doppler signal power values by the mean background power for corresponding depths of the depth range.
4. The method of claim 3 wherein determining from the signal-to- background data the presence of microemboli in the blood flow during the period of monitoring comprises: identifying the signal-to-background data representing a signal-to-background ratio greater than a threshold value.
5. The method of claim 2 wherein calculating a value related to a power for the signals from microemboli in the blood flow comprises: dividing the signal-to-background data over the period of monitoring into sub- periods having corresponding portions of the signal-to-background data; cross-correlating the signal-to-background data for a first half-sub-period to the signal-to-background data for a second half-sub-period; calculating correlative data in response to cross-correlating the signal-to- background data for the first and second half-sub-periods of the sub-periods; summing the correlative data; converting the sum to a decibel value to be used as the value related to the power for the signals from microemboli in the blood flow.
6. The method of claim 5 wherein delivering ultrasound to a region in which blood flow is present comprises: delivering ultrasound from first and second ultrasound probes for bilateral monitoring of the region; wherein extracting, calculating, and determining are performed for echo signals resulting from the ultrasound delivered by the respective ultrasound probes to provide decibel values for each of the probes; calculating beam power for the ultrasound delivered by each probe; and the value related to the power for the microemboli is provided by weighting the decibel values for each of the probes in accordance with the beam power calculated for each probe.
7. The method of claim 1 wherein categorizing the signals from microemboli in blood flow comprises: categorizing the signals from microemboli in blood flow into at least one high grade in response to the value being greater than or equal to a threshold value; and in response to the value being less than the threshold value, the method further comprising: calculating a count value corresponding to a number of signals from microemboli in the blood flow; and categorizing the signals from microemboli in blood flow into one of a plurality of grades based on the count value.
8. The method of claim 1 wherein categorizing the signals from microemboli in blood flow into one of at least two grades comprises categorizing the signals from microemboli in blood flow into a grade of a six-level logarithmic scale.
9. The method of claim 1 , further comprising: in the event the value is greater than the threshold value, determining whether the signals from microemboli in the blood flow over a period of monitoring is graded as a first high grade or a second high grade for sub-periods of the period of monitoring.
10. A method for categorizing microemboli in blood flow monitored using a Doppler ultrasound system, the method comprising: assessing a power value for the microemboli in the blood flow during a period of monitoring; in response to the power value being greater than or equal to a threshold value, categorizing the microemboli in the blood flow based on the power value; and in response to the power value being less than the threshold value, counting a number of microemboli during at least a portion of the period of monitoring and categorizing the microemboli based on the number.
11. The method of claim 10 wherein assessing a power value for the microemboli in the blood flow during a period of monitoring comprises assessing a power value for bubble emboli in cerebral blood flow during the period of monitoring.
12. The method of claim 11 wherein categorizing the microemboli in the blood flow based on the power value comprises categorizing the bubble emboli in a grade for a grading scale related to functional conductance of patent foramen ovale.
13. A Doppler ultrasound system, comprising: a probe having an ultrasound transducer; a transmitter circuit operably coupled to the ultrasound transducer and configured to generate drive signals for driving the ultrasound transducer to deliver ultrasound; a receiver circuit operably coupled to the ultrasound transducer and configured to receive echo signals detected by the ultrasound transducer and generate in response thereto echo data representative of the echo signals; and a processing system operably coupled to the transmitter and receiver circuits and configured to control the transmit circuit in generating drive signals for the ultrasound transducer and configured to process the, echo data from the receiver circuit and extract therefrom Doppler shift signals represented by Doppler shift data, the processing system further configured to process the Doppler shift data to calculate a value related to a power for the signals from microemboli in blood flow and categorize the signals from microemboli in blood flow into one of at least two grades based on the calculated value.
14. The system of claim 13 wherein the processing system comprises a processor configured to extract Doppler shift signals from echo signals resulting from ultrasound delivered to a region in which blood flow is detected for a period of monitoring and a background period and configured to calculate signal-to-background data from the Doppler shift signals from the period of monitoring and the background period, the processor further configured to determine from the signal-to-background data the presence of signals from microemboli in the blood flow during the period of monitoring.
15. The system of claim 14 wherein the processor configured to calculate signal-to-background data from the Doppler shift signals comprises a processor configured to calculate mean background power for a depth range from the Doppler shift signals from the background period, calculate Doppler signal power values for the depth range over the period of monitoring from the Doppler shift signals from the period of monitoring, and divide the Doppler signal power values by the mean background power for corresponding depths of the depth range.
16. The system of claim 14 wherein the processing system configured to process the Doppler shift data to calculate a value related to a power for the signals from microemboli in blood flow comprises a processor configured to divide the signal- to-background data over the period of monitoring into sub-periods having corresponding portions of the signal-to-background data and cross-correlate the signal- to-background data for a first half-sub-period to the signal-to-background data for a second half-sub-period, the processor further configured to calculate correlative data in response to cross-correlating the signal-to-background data for the first and second half- sub-periods of the sub-periods, sum the correlative data, and convert the sum to a decibel value to be used as the value related to the power for the signals from microemboli in the blood flow.
17. The system of claim 16 wherein the probe comprises a first probe, the transmitter circuit comprises a first transmitter circuit, and the receiver circuit comprises a first receiver circuit, and the system further comprises a second probe having an ultrasound transducer, a second transmitter circuit operably coupled to the ultrasound transducer of the second probe, and a second receiver circuit operably coupled to the ultrasound transducer of the second probe, the processing system comprises a processor configured to control the first and second transmit and receive circuits to deliver ultrasound from first and second probes for bilateral monitoring of a region, and the extracting, calculating, and determining are performed for echo signals resulting from the ultrasound delivered by the respective ultrasound probes to provide decibel values for each of the probes, the processor further configured to calculate beam power for the ultrasound delivered by each probe and calculate the value related to the power for the microemboli by weighting the decibel values for each of the probes in accordance with the beam power calculated for each probe.
18. The system of claim 13 wherein the processing system configured to categorize the signals from microemboli in blood flow comprises a processor configured to categorize the signals from microemboli in blood flow into at least one high grade in response to the value being greater than or equal to a threshold value and in response to the value being less than the threshold value, the processor is further configured to calculate a count value corresponding to a number of signals from microemboli in the blood flow and categorize the signals from microemboli in blood flow into one of a plurality of grades based on the count value.
19. The system of claim 13 wherein the processing system comprises a processor configured to determine whether the signals from microemboli in the blood flow over a period of monitoring is graded as a first high grade or a second high grade for sub-periods of the period of monitoring in the event the value is greater than a threshold value.
20. A processing system for a Doppler ultrasound system having a probe having an ultrasound transducer, transmit beam forming circuits, and receive beam forming circuits, the processing system comprising: a processor configured to extract Doppler shift signals from echo signals detected by the beam forming circuits and further configured to process the Doppler shift signals to assess a power value for microembdli in blood flow monitored by the Doppler ultrasound system during a period of monitoring and categorize microemboli in blood flow based on the power value in response to the power value being greater than or equal to a threshold value, the processor further configured to count a number of microemboli in blood flow during at least a portion of the period of monitoring and categorize the microemboli in blood flow based on the number in response to the power value being less than the threshold value.
21. The system of claim 20 wherein the processor configured to assess a power value for microemboli in the blood flow during a period of monitoring comprises a processor configured to assess a power value for bubble emboli in cerebral blood flow during the period of monitoring.
22. The system of claim 21 wherein the processor is configured categorize the bubble emboli in a grade for a grading scale related to functional conductance of patent foramen ovale.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06760242A EP1893095A4 (en) | 2005-05-20 | 2006-05-18 | System and method for grading microemboli monitored by a multi-gate doppler ultrasound system |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/134,862 | 2005-05-20 | ||
US11/134,862 US7771358B2 (en) | 2005-05-20 | 2005-05-20 | System and method for grading microemboli monitored by a multi-gate doppler ultrasound system |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006127542A2 true WO2006127542A2 (en) | 2006-11-30 |
WO2006127542A3 WO2006127542A3 (en) | 2007-02-01 |
Family
ID=37449185
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2006/019637 WO2006127542A2 (en) | 2005-05-20 | 2006-05-18 | System and method for grading microemboli monitored by a multi-gate doppler ultrasound system |
Country Status (4)
Country | Link |
---|---|
US (1) | US7771358B2 (en) |
EP (1) | EP1893095A4 (en) |
TW (1) | TW200701954A (en) |
WO (1) | WO2006127542A2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7771358B2 (en) * | 2005-05-20 | 2010-08-10 | Spentech, Inc. | System and method for grading microemboli monitored by a multi-gate doppler ultrasound system |
EA014286B1 (en) * | 2009-12-04 | 2010-10-29 | Закрытое Акционерное Общество "Научно-Производственная Фирма "Биосс" | Method for determining microemboli in cerebral blood flow |
US8162837B2 (en) | 2005-06-13 | 2012-04-24 | Spentech, Inc. | Medical doppler ultrasound system for locating and tracking blood flow |
RU2587310C1 (en) * | 2015-04-07 | 2016-06-20 | Закрытое акционерное общество "СПЕКТРОМЕД" | Method of determining and differentiation microemboluses in brain blood stram by means of ultrasonic doppler system |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8506519B2 (en) * | 1999-02-16 | 2013-08-13 | Flowcardia, Inc. | Pre-shaped therapeutic catheter |
US6855123B2 (en) | 2002-08-02 | 2005-02-15 | Flow Cardia, Inc. | Therapeutic ultrasound system |
US7399279B2 (en) * | 1999-05-28 | 2008-07-15 | Physiosonics, Inc | Transmitter patterns for multi beam reception |
US8133236B2 (en) * | 2006-11-07 | 2012-03-13 | Flowcardia, Inc. | Ultrasound catheter having protective feature against breakage |
US9955994B2 (en) | 2002-08-02 | 2018-05-01 | Flowcardia, Inc. | Ultrasound catheter having protective feature against breakage |
US7137963B2 (en) | 2002-08-26 | 2006-11-21 | Flowcardia, Inc. | Ultrasound catheter for disrupting blood vessel obstructions |
US7335180B2 (en) | 2003-11-24 | 2008-02-26 | Flowcardia, Inc. | Steerable ultrasound catheter |
US6942677B2 (en) | 2003-02-26 | 2005-09-13 | Flowcardia, Inc. | Ultrasound catheter apparatus |
US7758510B2 (en) | 2003-09-19 | 2010-07-20 | Flowcardia, Inc. | Connector for securing ultrasound catheter to transducer |
US7540852B2 (en) | 2004-08-26 | 2009-06-02 | Flowcardia, Inc. | Ultrasound catheter devices and methods |
US8221343B2 (en) | 2005-01-20 | 2012-07-17 | Flowcardia, Inc. | Vibrational catheter devices and methods for making same |
US9282984B2 (en) * | 2006-04-05 | 2016-03-15 | Flowcardia, Inc. | Therapeutic ultrasound system |
US8246643B2 (en) | 2006-11-07 | 2012-08-21 | Flowcardia, Inc. | Ultrasound catheter having improved distal end |
US20100069757A1 (en) * | 2007-04-27 | 2010-03-18 | Hideki Yoshikawa | Ultrasonic diagnostic apparatus |
US20100016731A1 (en) * | 2008-07-15 | 2010-01-21 | Cardiox Corporation | Hemodynamic Detection of Circulatory Anomalies |
TWM354841U (en) * | 2008-08-22 | 2009-04-11 | Wistron Corp | Waterproof pushbutton, and the assembly of waterproof pushbutton and electronic device housing |
US20110082373A1 (en) * | 2009-06-04 | 2011-04-07 | Gurley John C | Methods and apparatus for the detection of cardiopulmonary defects |
US8226566B2 (en) | 2009-06-12 | 2012-07-24 | Flowcardia, Inc. | Device and method for vascular re-entry |
WO2012023140A1 (en) | 2010-08-18 | 2012-02-23 | Sasi Solomon | Device and method for detecting an embolus moving in a blood vessel |
KR101313220B1 (en) * | 2010-11-23 | 2013-09-30 | 삼성메디슨 주식회사 | Ultrasound system and method for providing color doppler mode image based on qualification curve |
US8449565B2 (en) * | 2011-07-21 | 2013-05-28 | Francis Duhay | Approaches to venous occlusion for embolus management |
JP2014521462A (en) | 2011-08-05 | 2014-08-28 | シルク・ロード・メディカル・インコーポレイテッド | Method and system for treating acute ischemic stroke |
CA2857320C (en) | 2012-01-18 | 2020-08-11 | Bard Peripheral Vascular, Inc. | Vascular re-entry device |
US10238895B2 (en) | 2012-08-02 | 2019-03-26 | Flowcardia, Inc. | Ultrasound catheter system |
US9265512B2 (en) | 2013-12-23 | 2016-02-23 | Silk Road Medical, Inc. | Transcarotid neurovascular catheter |
EP3620204B1 (en) | 2015-02-04 | 2022-09-14 | Route 92 Medical, Inc. | Rapid aspiration thrombectomy system |
US11065019B1 (en) | 2015-02-04 | 2021-07-20 | Route 92 Medical, Inc. | Aspiration catheter systems and methods of use |
WO2016205824A1 (en) | 2015-06-19 | 2016-12-22 | Neural Analytics, Inc. | Transcranial doppler probe |
WO2017019563A1 (en) | 2015-07-24 | 2017-02-02 | Route 92 Medical, Inc. | Anchoring delivery system and methods |
US11589836B2 (en) | 2016-01-05 | 2023-02-28 | Novasignal Corp. | Systems and methods for detecting neurological conditions |
US10617388B2 (en) | 2016-01-05 | 2020-04-14 | Neural Analytics, Inc. | Integrated probe structure |
EP3399918A4 (en) | 2016-01-05 | 2019-08-21 | Neural Analytics, Inc. | Systems and methods for determining clinical indications |
CN113350655B (en) | 2016-02-24 | 2024-03-19 | 禾木(中国)生物工程有限公司 | Nerve vascular catheter with enhanced flexibility |
US20180140321A1 (en) | 2016-11-23 | 2018-05-24 | C. R. Bard, Inc. | Catheter With Retractable Sheath And Methods Thereof |
US11596726B2 (en) | 2016-12-17 | 2023-03-07 | C.R. Bard, Inc. | Ultrasound devices for removing clots from catheters and related methods |
US10758256B2 (en) | 2016-12-22 | 2020-09-01 | C. R. Bard, Inc. | Ultrasonic endovascular catheter |
US10653426B2 (en) | 2017-01-06 | 2020-05-19 | Incept, Llc | Thromboresistant coatings for aneurysm treatment devices |
EP4134120A1 (en) | 2017-01-10 | 2023-02-15 | Route 92 Medical, Inc. | Aspiration catheter systems |
US10582983B2 (en) | 2017-02-06 | 2020-03-10 | C. R. Bard, Inc. | Ultrasonic endovascular catheter with a controllable sheath |
US11278261B1 (en) | 2017-06-01 | 2022-03-22 | PFOmetrix, LLC | Apparatus, system and method for the detection and quantification of conductance of right-to-left cardiac shunts |
CA3095844A1 (en) | 2018-05-01 | 2019-11-07 | Incept, Llc | Devices and methods for removing obstructive material from an intravascular site |
US11395665B2 (en) | 2018-05-01 | 2022-07-26 | Incept, Llc | Devices and methods for removing obstructive material, from an intravascular site |
CN115920204A (en) | 2018-05-17 | 2023-04-07 | 92号医疗公司 | Aspiration catheter system and method of use |
US11517335B2 (en) | 2018-07-06 | 2022-12-06 | Incept, Llc | Sealed neurovascular extendable catheter |
US11471582B2 (en) | 2018-07-06 | 2022-10-18 | Incept, Llc | Vacuum transfer tool for extendable catheter |
US11426229B2 (en) * | 2019-02-21 | 2022-08-30 | Medtronic Navigation, Inc. | Method and apparatus for magnetic resonance imaging thermometry |
US11766539B2 (en) | 2019-03-29 | 2023-09-26 | Incept, Llc | Enhanced flexibility neurovascular catheter |
WO2020210344A1 (en) * | 2019-04-09 | 2020-10-15 | Massachusetts Institute Of Technology | Emboli detection methods to identify mechanisms of brain injury in susceptible adults and children |
CN113347916A (en) | 2019-10-15 | 2021-09-03 | 因普瑞缇夫护理公司 | System and method for multivariate stroke detection |
EP4076611A4 (en) | 2019-12-18 | 2023-11-15 | Imperative Care, Inc. | Methods and systems for treating venous thromboembolic disease |
US11633272B2 (en) | 2019-12-18 | 2023-04-25 | Imperative Care, Inc. | Manually rotatable thrombus engagement tool |
US11259821B2 (en) | 2019-12-18 | 2022-03-01 | Imperative Care, Inc. | Aspiration system with accelerated response |
AU2021235887A1 (en) | 2020-03-10 | 2022-09-08 | Imperative Care, Inc. | Enhanced flexibility neurovascular catheter |
US11986342B2 (en) * | 2020-05-18 | 2024-05-21 | Agitated Solutions Inc. | Characterization of cardiac shunts with bubbles |
US20230389888A1 (en) * | 2020-05-18 | 2023-12-07 | Agitated Solutions Inc. | Automated echocardiogram processing to characterize shunts |
US11207497B1 (en) | 2020-08-11 | 2021-12-28 | Imperative Care, Inc. | Catheter with enhanced tensile strength |
CN113069148A (en) * | 2021-06-04 | 2021-07-06 | 南京左右脑医疗科技有限公司 | Method for automatically identifying gas and solid embolus signals |
Family Cites Families (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4015464A (en) * | 1975-02-21 | 1977-04-05 | The Washington University | Ultrasonic continuous wave particle monitor |
US4014206A (en) * | 1975-03-31 | 1977-03-29 | Akron City Hospital | Apparatus and method for monitoring air emboli during extracorporeal circulation |
US4152928A (en) * | 1977-05-02 | 1979-05-08 | University Patents, Inc. | System for detecting fat particles in blood |
US4319580A (en) * | 1979-08-28 | 1982-03-16 | The Board Of Regents Of The University Of Washington | Method for detecting air emboli in the blood in an intracorporeal blood vessel |
US4276491A (en) * | 1979-10-02 | 1981-06-30 | Ausonics Pty. Limited | Focusing piezoelectric ultrasonic medical diagnostic system |
JPS5883942A (en) * | 1981-11-12 | 1983-05-19 | 株式会社東芝 | Ultrasonic pulse doppler apparatus |
NO831718L (en) * | 1983-05-13 | 1984-11-14 | Vingmed As | PROCEDURE AND APPARATUS AT BLOOD STREET SPEED MEASUREMENT WITH ULTRO SOUND FOR BODY-TIME DIMENSIONAL IMAGE OF BLOOD SPEED |
US4537074A (en) * | 1983-09-12 | 1985-08-27 | Technicare Corporation | Annular array ultrasonic transducers |
GB8409455D0 (en) * | 1984-04-12 | 1984-05-23 | Lucas Ind Plc | Electrical connector |
JPS61170442A (en) * | 1985-01-23 | 1986-08-01 | 松下電器産業株式会社 | Ultrasonic doppler blood flow apparatus |
JPH0693890B2 (en) * | 1985-04-30 | 1994-11-24 | 株式会社東芝 | Ultrasonic diagnostic equipment |
JPH0613031B2 (en) * | 1987-08-12 | 1994-02-23 | 株式会社東芝 | Ultrasonic blood flow imaging device |
US4800891A (en) * | 1987-11-13 | 1989-01-31 | Siemens Medical Laboratories, Inc. | Doppler velocity processing method and apparatus |
US4932415A (en) * | 1988-11-14 | 1990-06-12 | Vingmed Sound A/S | Method of color coding two dimensional ulltrasonic doppler velocity images of blood flow on a display |
US4993418A (en) | 1989-01-26 | 1991-02-19 | Minnesota Mining And Manufacturing Company | Doppler blood flow system and method using low frequency noise signal processing |
JPH02291847A (en) * | 1989-05-02 | 1990-12-03 | Toshiba Corp | Ultrasonic blood flow measuring apparatus |
JPH02307436A (en) * | 1989-05-23 | 1990-12-20 | Toshiba Corp | Ultrasonic blood flow imaging apparatus |
JPH0614932B2 (en) * | 1989-05-29 | 1994-03-02 | 株式会社東芝 | Ultrasonic diagnostic equipment |
JP2777197B2 (en) * | 1989-06-13 | 1998-07-16 | 株式会社東芝 | Ultrasound diagnostic equipment |
FR2655260A1 (en) * | 1989-12-01 | 1991-06-07 | Philips Electronique Lab | DEVICE FOR MEASUREMENT AND VISUALIZATION BY ULTRASONIC ECHOGRAPHY OF PHYSIOLOGICAL PARAMETERS OF A BLOOD FLOW. |
US5190044A (en) * | 1990-03-30 | 1993-03-02 | Kabushiki Kaisha Toshiba | Ultrasonic blood flow imaging apparatus |
US5053008A (en) * | 1990-11-21 | 1991-10-01 | Sandeep Bajaj | Intracardiac catheter |
US5103827A (en) * | 1990-12-14 | 1992-04-14 | Medasonics, Inc. | Apparatus for and a method of distinguishing ultrasound signals returned from bubbles and particles moving in a fluid from signals due to ultrasound transducer motion |
US5101828A (en) * | 1991-04-11 | 1992-04-07 | Rutgers, The State University Of Nj | Methods and apparatus for nonivasive monitoring of dynamic cardiac performance |
JP3070133B2 (en) * | 1991-05-28 | 2000-07-24 | 株式会社日立メディコ | Ultrasound diagnostic equipment |
US5271404A (en) * | 1992-06-25 | 1993-12-21 | Cardiometrics, Inc. | Method and apparatus for processing signal data to form an envelope on line |
US5348015A (en) * | 1992-09-17 | 1994-09-20 | Applied Physiology And Medicine | Method and apparatus for ultrasonically detecting, counting and/or characterizing emboli |
US5394732A (en) | 1993-09-10 | 1995-03-07 | Cobe Laboratories, Inc. | Method and apparatus for ultrasonic detection of air bubbles |
JP3833282B2 (en) * | 1994-06-24 | 2006-10-11 | 株式会社東芝 | Ultrasonic diagnostic equipment |
US5615680A (en) * | 1994-07-22 | 1997-04-01 | Kabushiki Kaisha Toshiba | Method of imaging in ultrasound diagnosis and diagnostic ultrasound system |
US5476097A (en) * | 1994-10-13 | 1995-12-19 | Advanced Technology Laboratories, Inc. | Simultaneous ultrasonic imaging and Doppler display system |
US5501223A (en) * | 1994-11-23 | 1996-03-26 | General Electric Company | Dynamic firing sequence for ultrasound imaging apparatus |
WO1996021215A1 (en) | 1994-12-30 | 1996-07-11 | Acuson Corporation | Imaging modality showing energy and velocity |
US5441051A (en) * | 1995-02-09 | 1995-08-15 | Hileman; Ronald E. | Method and apparatus for the non-invasive detection and classification of emboli |
US5590658A (en) * | 1995-06-29 | 1997-01-07 | Teratech Corporation | Portable ultrasound imaging system |
JPH0975348A (en) * | 1995-09-12 | 1997-03-25 | Toshiba Corp | Ultrasonic diagnostic equipment |
JP3707882B2 (en) * | 1995-11-21 | 2005-10-19 | 株式会社東芝 | Ultrasonic diagnostic equipment |
US5622173A (en) * | 1995-12-21 | 1997-04-22 | Hewlett-Packard Company | Color flow display with compensation for flow direction |
US5724974A (en) * | 1996-03-22 | 1998-03-10 | Acuson Corporation | Two-dimensional ultrasound display system |
JP3713329B2 (en) * | 1996-06-04 | 2005-11-09 | 株式会社東芝 | Ultrasonic Doppler diagnostic device |
US5722412A (en) * | 1996-06-28 | 1998-03-03 | Advanced Technology Laboratories, Inc. | Hand held ultrasonic diagnostic instrument |
JP3946288B2 (en) * | 1996-10-01 | 2007-07-18 | 東芝医用システムエンジニアリング株式会社 | Ultrasonic color Doppler diagnostic apparatus and signal processing method for ultrasonic color Doppler imaging |
JP3771978B2 (en) * | 1996-10-31 | 2006-05-10 | 株式会社東芝 | Ultrasonic diagnostic equipment |
US5833615A (en) * | 1997-05-09 | 1998-11-10 | Thomas Jefferson University | Excitation enhanced ultrasound system |
US5800356A (en) * | 1997-05-29 | 1998-09-01 | Advanced Technology Laboratories, Inc. | Ultrasonic diagnostic imaging system with doppler assisted tracking of tissue motion |
US6050944A (en) * | 1997-06-17 | 2000-04-18 | Acuson Corporation | Method and apparatus for frequency control of an ultrasound system |
US5944666A (en) * | 1997-08-21 | 1999-08-31 | Acuson Corporation | Ultrasonic method for imaging blood flow including disruption or activation of contrast agent |
US5928151A (en) * | 1997-08-22 | 1999-07-27 | Acuson Corporation | Ultrasonic system and method for harmonic imaging in three dimensions |
US5919139A (en) * | 1997-12-19 | 1999-07-06 | Diasonics Ultrasound | Vibrational doppler ultrasonic imaging |
US5882315A (en) * | 1997-12-23 | 1999-03-16 | Acuson Corporation | Ultrasonic imaging method and image for doppler tissue parameters |
US5997478A (en) * | 1998-02-03 | 1999-12-07 | Acuson Corporation | Ultrasound system and method for facilitating a reproducible ultrasound imaging environment |
US6547732B2 (en) * | 1998-10-01 | 2003-04-15 | Koninklijke Philips Electronics N.V. | Adaptive image processing for spatial compounding |
US6196972B1 (en) * | 1998-11-11 | 2001-03-06 | Spentech, Inc. | Doppler ultrasound method and apparatus for monitoring blood flow |
US6524249B2 (en) * | 1998-11-11 | 2003-02-25 | Spentech, Inc. | Doppler ultrasound method and apparatus for monitoring blood flow and detecting emboli |
US6547736B1 (en) * | 1998-11-11 | 2003-04-15 | Spentech, Inc. | Doppler ultrasound method and apparatus for monitoring blood flow and detecting emboli |
US7534209B2 (en) * | 2000-05-26 | 2009-05-19 | Physiosonics, Inc. | Device and method for mapping and tracking blood flow and determining parameters of blood flow |
US6408679B1 (en) | 2000-02-04 | 2002-06-25 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Bubble measuring instrument and method |
US6635017B1 (en) * | 2000-02-09 | 2003-10-21 | Spentech, Inc. | Method and apparatus combining diagnostic ultrasound with therapeutic ultrasound to enhance thrombolysis |
US6468219B1 (en) | 2000-04-24 | 2002-10-22 | Philip Chidi Njemanze | Implantable telemetric transcranial doppler device |
US6482161B1 (en) * | 2000-06-29 | 2002-11-19 | Acuson Corporation | Medical diagnostic ultrasound system and method for vessel structure analysis |
US6503202B1 (en) * | 2000-06-29 | 2003-01-07 | Acuson Corp. | Medical diagnostic ultrasound system and method for flow analysis |
JP3812304B2 (en) * | 2000-08-09 | 2006-08-23 | 三菱自動車工業株式会社 | Anti-vibration support structure |
US7128713B2 (en) * | 2003-07-10 | 2006-10-31 | Spentech, Inc. | Doppler ultrasound method and apparatus for monitoring blood flow and hemodynamics |
JP4473543B2 (en) * | 2003-09-05 | 2010-06-02 | 株式会社東芝 | Ultrasonic diagnostic equipment |
US20050251041A1 (en) * | 2004-05-07 | 2005-11-10 | Moehring Mark A | Doppler ultrasound processing system and method for concurrent acquisition of ultrasound signals at multiple carrier frequencies, embolus characterization system and method, and ultrasound transducer |
US7771358B2 (en) * | 2005-05-20 | 2010-08-10 | Spentech, Inc. | System and method for grading microemboli monitored by a multi-gate doppler ultrasound system |
US8162837B2 (en) * | 2005-06-13 | 2012-04-24 | Spentech, Inc. | Medical doppler ultrasound system for locating and tracking blood flow |
WO2007022055A1 (en) * | 2005-08-12 | 2007-02-22 | Massicotte J Mathieu | Method and device for extracting objects from the body |
-
2005
- 2005-05-20 US US11/134,862 patent/US7771358B2/en not_active Expired - Fee Related
-
2006
- 2006-05-18 WO PCT/US2006/019637 patent/WO2006127542A2/en active Application Filing
- 2006-05-18 EP EP06760242A patent/EP1893095A4/en not_active Withdrawn
- 2006-05-19 TW TW095117993A patent/TW200701954A/en unknown
Non-Patent Citations (1)
Title |
---|
See references of EP1893095A4 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7771358B2 (en) * | 2005-05-20 | 2010-08-10 | Spentech, Inc. | System and method for grading microemboli monitored by a multi-gate doppler ultrasound system |
US8162837B2 (en) | 2005-06-13 | 2012-04-24 | Spentech, Inc. | Medical doppler ultrasound system for locating and tracking blood flow |
EA014286B1 (en) * | 2009-12-04 | 2010-10-29 | Закрытое Акционерное Общество "Научно-Производственная Фирма "Биосс" | Method for determining microemboli in cerebral blood flow |
RU2587310C1 (en) * | 2015-04-07 | 2016-06-20 | Закрытое акционерное общество "СПЕКТРОМЕД" | Method of determining and differentiation microemboluses in brain blood stram by means of ultrasonic doppler system |
Also Published As
Publication number | Publication date |
---|---|
EP1893095A2 (en) | 2008-03-05 |
EP1893095A4 (en) | 2010-01-06 |
US7771358B2 (en) | 2010-08-10 |
US20060264759A1 (en) | 2006-11-23 |
TW200701954A (en) | 2007-01-16 |
WO2006127542A3 (en) | 2007-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7771358B2 (en) | System and method for grading microemboli monitored by a multi-gate doppler ultrasound system | |
JP5150267B2 (en) | Ultrasound diagnostic imaging system to detect liver damage | |
Zhou et al. | Hepatic steatosis assessment with ultrasound small-window entropy imaging | |
US6508767B2 (en) | Ultrasonic harmonic image segmentation | |
US10482601B2 (en) | Evaluation of carotid plaque using contrast enhanced ultrasonic imaging | |
JP5680654B2 (en) | Ultrasonic diagnostic apparatus and ultrasonic image display method | |
US20110208061A1 (en) | Ultrasonic lesion identification using temporal parametric contrast images | |
JP2004520875A (en) | Doppler ultrasound method for detecting emboli | |
JP5481108B2 (en) | Ultrasonic diagnostic apparatus and automatic diagnosis support apparatus | |
JPH08511982A (en) | Device and method for detecting vascular flow during intravascular ultrasound imaging | |
US20150025380A1 (en) | Ultrasound diagnosis apparatus, image processing apparatus and image processing method | |
JP5389118B2 (en) | Ultrasonic diagnostic equipment | |
JPH08308831A (en) | Ultrasonic diagnostic device | |
JP3578680B2 (en) | Ultrasound diagnostic equipment | |
van der Ven et al. | High-frame-rate power Doppler ultrasound is more sensitive than conventional power Doppler in detecting rheumatic vascularisation | |
JP5300171B2 (en) | Ultrasonic diagnostic apparatus, ultrasonic image processing apparatus, and ultrasonic image processing program | |
EP3179269B1 (en) | Analysis methods of ultrasound echo signals based on statistics of scatterer distributions | |
Torres et al. | In vivo delineation of carotid plaque features with ARFI variance of acceleration (VoA): Clinical results | |
WO2007119609A1 (en) | Embolus observing method and device, and ultrasonograph using them | |
JP4398024B2 (en) | Ultrasonic diagnostic device and thrombus imaging device | |
EP4275612A1 (en) | Improvements in ultrasound based blood flow velocity measurements | |
Torres et al. | Harmonic Imaging Improves Delineation of Human Carotid Plaque Features by ARFI Variance of Acceleration | |
Shaharabany et al. | A sensitive new indicator for diagnostics of ovarian malignancy, based on the Doppler velocity spectrum | |
Ménigot et al. | Automatic detection of microemboli by means of a synchronous linear prediction technique | |
Thomas et al. | The contribution of spectral analysis to the diagnosis of carotid artery disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2006760242 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006760242 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: RU |